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During peri-implantation, the embryo transitions from a suspension environment 
in the fallopian tubes to an adherent system within the uterus. Successful 
transition requires maternal and fetal signaling cascades that establish maternal-
fetal boundaries. Failure is common, as ~ 25% of all human pregnancies 
terminate during these steps. A large-scale mutation study in mice produced two 
mutants (l11Jus1 and l11Jus4) that are excellent models of this transition. 
l11Jus1 and l11Jus4 contain missense mutations in the Notchless homolog 1 
(Drosophila) (Nle1) gene. NLE1 is thought to signal via the canonical NOTCH 
pathway in vertebrates. Although in invertebrates and lower vertebrates, NOTCH 
signaling directs cell fate prior to gastrulation, it is dispensable for gastrulation in 
mice. Moreover, in yeast and plants, which lack NOTCH signaling, Nle1 is crucial 
for ribosome biogenesis. These seemingly contradictory data led me to 
hypothesize that mutation of Nle1 causes a lethal trauma to the embryo that 
disrupts multiple signaling pathways during peri-implantation development. I 
present data that: 1. Refute the presumption that Nle1 functions as a negative 
regulator of NOTCH during pre-implantation development; 2. Demonstrate that 
mutations in Nle1 lead to mis-expression of several members of the Wnt pathway; 
and 3. Show that mutant embryos enter cell cycle arrest; when that fails, they 





precipitated these lethal cascades, I discovered that Nle1 mutants display delays 
in ribosomal RNA processing and nucleogenesis. These results uncover novel 
functions for NLE1 in the ribosomal biogenesis, TRP53 and WNT pathways 














1.1 Signaling During Peri-implantation Development 
 
During peri-implantation, the embryo transitions from a free-flowing suspension 
environment (i.e. pre-implantation development) in the oviduct (mice) or fallopian 
tubes (humans) to an adherent system within the uterus. Pre-implantation 
development occurs between fertilization and the blastocyst stage. After 
fertilization, the totipotent zygote undergoes a series of cell divisions as well as 
morphological changes whereby it reaches the morula and blastocyst stage (Fig. 
1.1). In mice, embryos usually become blastocysts by embryonic day 3.5 (E3.5), 
where E0.5 is 12 hours post coitus. A blastocyst is characterized by the presence 
of an inner cell mass (ICM) toward one end and a fluid-filled cavity (blastocoel) 
on the other (Doetschman et al., 1985; Gardner and Johnson, 1972). The inner 
cell mass and blastocoel are surrounded by the trophectoderm. The ICM 
differentiates into two cell layers, called the epiblast and primitive endoderm. The 
epiblast is slated to become the embryo property, while the primitive endoderm 
forms the yolk sac. The trophectoderm develops into the embryonic portion of the 
placenta (Tarkowski et al., 2010). The zona pellucida (ZP) surrounds the entire 
blastocyst, and is produced by the oocyte during maturation to prevent 
polyspermy and protect the embryo through early development until the 
blastocyst stage (Bleil et al., 1981).  
 
During the late blastocyst stage, the blastocoel expands, causing hydrostatic 






enzymatic degradation, the embryo gradually egresses from the zona pellucida in 
a process called hatching (Bergstrom, 1972; Seshagiri et al., 2009). The hatched
blastocyst is now ready for implantation. Mouse embryos implant between E4.5 
to E5.5. At this time point, the blastocyst attaches itself to the maternal cells and 
the trophectoderm invades the luminal endothelium of the uterus (Johnson and 
McConnell, 2004; Red-Horse et al., 2004).  
 
After implantation, the embryo undergoes gastrulation, which is the generation of 
three germ layers from the epiblast: ectoderm, mesoderm, and endoderm. The 
ectoderm becomes the epithelium and nervous system. The mesoderm forms 
somites and notochord that eventually produce muscles, as well as the 
circulatory and excretory systems. The endoderm develops into all the digestive 
and respiratory tracks of the body (Keller, 1981; Sweeton et al., 1991; Williams et 
al., 2012; Yamanaka et al., 2007). 
 
Figure 1.1 Mouse pre-implantation development 
Early embryonic stages from the zygote (fertilized egg) to a hatched blastocyst 
are shown. Embryos are surrounding by the zona pellucida until the late 
blastocyst stage. The polar body is the by-product of the second meiotic division 
and can be found in the embryo until the 4-cell stage. E0.5 is denoted as 12 
hours after fertilization. At E3.5, the embryo shows distinct cell specification of 
Zygote 2-Cell stage 
  E0.5             E1.5                 E2             E2.5-3.5         E3.5           E3.5-E4.5        
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the inner cell mass (ICM) and trophectoderm. The ICM differentiates into the 
epiblast and primitive endoderm. 
 
Successful transition of the embryo to the uterine environment requires maternal 
and fetal signal transduction cascades that establish and/or maintain maternal-
fetal boundaries. Studies in humans underscore the importance of these events, 
as 25% of all pregnancies are predicted to end in miscarriage by this transition 
(Rai and Regan, 2006). According to the American Pregnancy Association 
(http://americanpregnancy.org/), miscarriage is the spontaneous loss of 
pregnancy before the fetus is viable, and includes all pregnancy loss before or at 
24 weeks of gestation. The numbers are staggering, as 25% of women 
experience at least one miscarriage in their lives (Stephenson and Kutteh, 2007). 
Although 15-20% of clinically recognized pregnancies will end in miscarriage, 
upwards of 50% of all pregnancies are predicted to end in miscarriage (Rai and 
Regan, 2006).  
 
Although most miscarriage is attributed to sporadic chromosomal deficits, 
infection, structural abnormalities, and endocrine problems that often cannot be 
detected or controlled in a timely manner, a significant number of women suffer 
from recurrent miscarriage, which may have a genetic component (Rai and 
Regan, 2006). Recurrent miscarriage is defined as three or more consecutive 
pregnancy losses and occurs in 1-5% of couples (Jaslow et al., 2010; 
Stephenson et al., 2002). Several causes can lead to miscarriage. Some of the 
most common cases during the first trimester, and in particular in recurrent 
miscarriage, are caused from genetic abnormalities (Nathan, 2007). Peri-
implantation is one critical window where genetic, epigenetic, and environmental 
factors coordinate embryonic and maternal gene regulation. Correct gene 
expression and timing are critical for establishing maternal-fetal interactions, and 







The regulation of peri-implantation development involves multiple pathways, such 
as NOTCH, WNT and ribosomal biogenesis. Although disruption of NOTCH 
signaling in mice indicates that NOTCH signaling is not necessary for 
implantation, all NOTCH receptors and their ligands are detected during pre-
implantation development. And recent studies that knocked down γ-secretase, 
which cleaves the intracellular domain of NOTCH so that it can translocate to the 
nucleus to initiate downstream target genes, indicate that γ-secretase levels are 
important for blastocyst competency (Chu et al., 2011). This study contradicts 
gene-targeting reports (Shi et al., 2005), and suggests that γ-secretase levels 
could be imperative during pre-implantation development. Although gene-
targeting studies indicate that the canonical Wnt pathway is not necessary during 
pre-implantation development (de Vries et al., 2004), non-canonical Wnt 
signaling is critical for cross-talk between the blastocyst and the uterine 
environment (de Vries et al., 2004; Mohamed et al., 2004; Xie et al., 2008), and 
successful implantation requires an activated blastocyst and a receptive uterine 
niche. While uterine receptivity depends primarily on estrogen and progesterone 
(Dey et al., 2004), a variety of factors are crucial for blastocyst activation, 
including the cannabinoid, MAPK and Erb1/2 receptors (Wang and Dey, 2006). 
Ribosome biogenesis is the process by which a 47S pre-rRNA is systematically 
cleaved into mature rRNAs that will be incorporated into ribosomal subunits. 
Mutations in genes involved in ribosome biogenesis have deleterious effects 
during pre-implantation development (Lerch-Gaggl et al., 2002; Yamamura et al., 
2008; Romanova et al., 2006; Zhang et al., 2008; Ding et al., 2010; Gallenberger 
et al., 2011; Vogt et al., 2012). These studies all show disruption in the nucleolus 
and increased cell apoptosis, which suggests that nucleolar proteins are 







1.2 NOTCH Signaling 
The NOTCH signaling pathway, first identified in Drosophila and conserved 
across species (Weinmaster et al., 1991), is involved in a wide range of biological 
processes from cell fate specification to tissue homeostasis (Artavanis-Tsakonas 
et al., 1999; Bolos et al., 2007). The name NOTCH comes from the appearance 
of notched wings in mutant fruit flies.  
The epidermal growth factor-like (EGF) repeats of the ligand’s extracellular 
domain interact with the EGF repeats 11 and 12 of the NOTCH receptors’ 
extracellular domain to initiate the signaling. This interaction causes the 
activation of A Disintegrin And Metalloproteinase (ADAM) 10 or 17 (Figure 1.2). 
The ADAMs cleave the extracellular domain of NOTCH, which is then cleaved by 
the S3 cleavage to release the NOTCH intracellular domain (NICD). NICD is the 
substrate of proteolytic gamma-secretase complex. The C-terminal of NOTCH 
translocates to the nucleus. The NOTCH intracellular domain does not contact 
DNA directly, that is, it needs to associate with a transcriptional factor. The well-
known NOTCH associated transcriptional factor is RBP-Jk (CSL), which contains 
the CGTGGGA recognition motif (Reichrath and Reichrath, 2012). The 
interaction between NICD and RBP-Jk recruits the coactivator Mastermind-Like 
(MAML) and the histone acetyltransferease p300. Kinase CDK8 later on 
phosphorylates NICD to become a substrate for ubitiquination degradation (Fryer 
et al., 2004). The NICD translocates to the nucleus, where it disrupts the 
repressor complex, leading to the activation of downstream target genes 
(Schroeter et al., 1998). NOTCH ligands are transmembrane proteins of the DSL 
(Delta/Serrate/LAG-2 like family). NOTCH 1, 2, 3, and 4 are the four 
transmembrane receptors on the surface of signal receiving cell that can be 
activated by one of the five canonical NOTCH ligands (Jagged 1, 2; Delta-like 1, 











Figure 1.2 NOTCH signaling pathway 
The red protein located on the signal sending cell is the ligand of NOTCH 
signaling, JAG1, 2 and DLL 1, 3, 5. The NOTCH receptor contains an 
extracellular domain that interacts with the ligand, a transmembrane domain, and 
an intracellular domain (NICD). After the binding of the NOTCH ligand on the 
receptor, NOTCH receptor is cleaved by ADAMs to release the extracellular 
domain and then follows by the cleavage by Υ-secreatase complex to release 
NICD. NICD is then translocated to the nucleus, displaces the co-repressors of 
NOTCH downstream target genes and histone deacetylase, and then recruits co-
activator of NOTCH and histone acetyltransferease to activate downstream gene 
expression.  
Signal sending cell 























Despite the simple ligand/receptor activation transduction, NOTCH also elicits 
another complex regulation that involves a posttranslational modification. 
Common posttranslational modifications are ubiquitination of the ligand, 
glycosylation and proteolytic cleavages of receptor, and the inhibiting 
ubiquitination of the receptor by the E3 ubiquitin ligase Numb (Lai, 2004). The 
most well known NOTCH target genes are members of the Hairy/Enhancer of 
Split family (Hes1, Hes5, Hes7) and the Hairy/Enhancer of Split related with 
YRPW motif family (Hey1, Hey2, Hey7). Hes genes are important for 
somitogenesis (i.e. mesoderm specification) and generation of the nervous 
system. The Hey family is critical for the development of the cardiovascular 
system (Fischer and Gessler, 2007). Gene regulation by NOTCH can be 
mediated by interactions between NICD and other partners. The most well-
characterized regulator is a DNA-binding protein called CSL (CBF1 in human, 
Su(H) in fruit fly, and LAG1 in C. elegans). CSL is also called RBPJ. CSL can 
both activate and suppress NOTCH target genes by associating with different 
binding partners (Persson and Wilson, 2010).  
 
The NOTCH signaling components are detected from the zygote stage 
throughout gestation (Ahnfelt-Ronne et al., 2012; Cormier et al., 2004b; Del 
Monte et al., 2007; Yoshikawa et al., 2006). Cormier et al. (Cormier et al., 2004b) 
examined the expression of genes that were directly or indirectly involved in the 
NOTCH pathway in the pre-implantation embryo development. Notch1-2, Jag1-2, 
Dll-3, Rbpj, and Dtx2 are expressed from unfertilized oocytes to late blastocyst 
stages; Notch 4 and Dll-4 transcripts are detected from two-cell stage to the 
hatched blastocyst stages. Notch 3, Dll1, and Dtx1 mRNA are found in two-cell 
embryos and in hatched blastocysts, but are not detectable at the morula stage. 
These results suggest that the NOTCH signaling pathway may be active during 
pre-implantation development. Using microarray, Wang et al. also uncovered that 
other genes of the NOTCH pathway, such as Fringe, Srrt, Psen1 and Dtx1 are 





NOTCH signaling is essential in regulating mid-gestation processes that include 
somitogenesis, lymphopoiesis, and vascular development in a CSL-dependant 
process (Conlon et al., 1995; Irvine, 1999; Lai, 2004; Palmeirim et al., 1997). 
However, NOTCH might act in a CSL-independent manner before gastrulation. 
Several lines of evidence demonstrate that NOTCH signaling is dispensable for 
gastrulation in mice. (Table 1.1) Single gene and compound knockout studies of 
the Notch receptors and ligands result in either viable animals or embryonic 
lethality at mid-gestation (Conlon et al., 1995; Dunwoodie et al., 2002; Hamada 
et al., 1999; Hrabe de Angelis et al., 1997; Jiang et al., 1998a; Jiang et al., 1998b; 
Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000; Krebs et al., 2003; 
McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion of genes that block 
NOTCH signaling, such as Pofut1 and members of the Υ-secretase complex, 
leads to embryonic failure after gastrulation and midline formation (Shi et al., 
2005b). This suggests that another regulator may play a similar role as CSL to 
















Table 1.1 Mutant lethality / phenotypes of the NOTCH signaling in mice 
Gene Mutation Phenotype Interaction References 
Notch 1 KO Lethal 
~E11.5 
Notch 4 (fail to turn 
at E9.5) 
Swiatek et al., 1994 
Notch 2 KO Lethal 
~E11.5 
 Hamada et al., 1999 
Notch 3 KO Normal None with Notch 1 Krebs et al., 2003 
Notch 4 KO Normal Notch 4 (fail to turn 
at E9.5) 
Krebs et al., 2003 
Delta 
Like-1 











KO Lethal ~E12  Krebs et al., 2004 
Jagged 1 KO Lethal 
~E11.5 
 Xue et al., 1999 















1.3 Wnt Signaling 
Wnt signaling is conserved from Drosophila to human, and it regulates a myriad 
of processes, including embryogenesis, cell fate specification, cell proliferation, 
and homeostasis in adult tissues (Logan and Nusse, 2004). Canonical Wnt 
signaling in mammals, which is mediated by β-catenin, includes 19 Wingless 
(WNT) ligands, 10 G-protein coupled frizzled receptors (FZD) and two low-
density lipoprotein receptor-related protein co-receptors (LRP-5 and 6) (Wodarz 
and Nusse, 1998). When a WNT ligand binds to the cysteine-rich domain of its 
cognizant FZD receptor, signaling induces heterodimerization of FZD-LRP and 
recruits Dishevelled (DSH) to the FZD-LRP dimmer, forming a complex called a 
signalosome (Bilic et al., 2007). β-catenin accumulates in the cytoplasm. β-
catenin translocates into the nucleus where it co-regulates transcription. The 
non-canonical pathway is poorly characterized and involves diverse receptors 
and downstream targets. Wnt/planar cell polarity (PCP) and Wnt/Ca2+ pathway 
are the two well-characterized non-canonical pathways. Binding of the non-
canonical WNT ligands to FZD results in DSH activation without the incorporation 
of LRP as a co-receptor (Sheldahl et al., 2003). Signaling then passes down to 
different downstream targets depending upon the interacting pathways.  
  
WNT signaling plays important roles in both embryo and the uterus to during 
implantation. In situ studies of the Frizzled (Fzd) genes indicate that Fzd5, Fzd7, 
and Fzd10 are detected in pre-gastrulation embryos (Kemp et al., 2005; Kemp et 
al., 2007), as well as in the uterus during peri-implantation (Hayashi et al., 2007; 
Hayashi et al., 2009a; Hayashi et al., 2009b; Miller and Sassoon, 1998). At the 
blastocyst stage, several Wnt genes, such as Wnt5a, Wnt7a, and Wnt11 are 
expressed at higher levels than in the morula stage (Mohamed et al. 2004). In 
addition, expression levels of Wnt7a, Wnt7b, Wnt11, and Wnt16 are much higher 
in the implantations sites of maternal uterus compared to non-implantation sites 
(Hayashi et al., 2009b). Moreover, in embryos where Wnt3 has been deleted, 





2007). However, depletion of both maternal and zygotic β-catenin does not 
disrupt blastocyst development (de Vries et al., 2004), indicating that canonical 
Wnt pathway is dispensable during pre-implantation development.  
 
Therefore, the non-canonical signaling may play a role in pre-implantation 
development. For example, overexpression of Dishevelled proteins, which 
transduce divergent Wnt pathways, disrupts cell-cell adhesion during pre-
implantation (Na et al., 2007). Dishevelled proteins regulate cell polarity and cell 
adhesion through non-canonical Wnt signaling (Fanto and McNeill, 2004; Moon 
et al., 1993). These data suggest that non-canonical Wnt pathway(s) may be 
active during pre-implantation development. Nevertheless, the canonical Wnt 
pathway becomes critical at implantation. Xie et al. (2008) showed that 
inactivation of zygotic nuclear Wnt-β-catenin signaling through activating Dkk1, a 
potent inhibitor of β-catenin, limits the competency of blastocysts to implant (Xie 
et al., 2008). This cascade initiates in the trophectoderm, which expands during 
implantation to invade the maternal decidua and form a protective environment 
for the developing embryo. As a whole, these studies suggest that Wnt signaling 
undergoes a switch from the non-canonical pathway in the early pre-implantation 
blastocyst to canonical signaling as the hatched blastocyst creates its protective 
niche within the uterine wall where it interacts with new signaling molecules in the 
maternal tissue (Xie et al., 2008).  
 
1.4 Ribosomal Biogenesis  
During early development, there is an increased demand in protein synthesis 
(Schultz et al., 1990). To meet the high protein requirements, the embryo must 
improve its translational capacity by up-regulating ribosomal biogenesis. 
Ribosomal biogenesis is a key process that governs protein synthesis and 
requires factors for processing rRNA, assembly, and transporting of ribosomal 
subunits from nucleolus to cytoplasm (Tschochner and Hurt, 2003). Alterations in 





embryogenesis or lead to detectable disease (Baserga et al., 2010; Fukuda et al., 
2008; Gallenberger et al., 2011; Zhang et al., 2008) 
 
Ribosomal biogenesis is a well-coordinated and evolutionarily conserved process 
that takes place in the nucleolus (Fromont-Racine et al., 2003). During mouse 
early embryo development, the nucleolus is exclusively maternally inherited. The 
maternal nucleolus disassembles after pronuclear fusion, and later on, the 
zygotic nucleolus is assembled when the embryonic genome becomes activated. 
The oocyte-originated nucleolar components are crucial for serving as the 
precursor materials that are required to reassemble the functional zygotic 
nucleoli (Ogushi et al., 2008). When the nucleolus is removed from the oocytes, 
about 80% of enucleolated oocytes can reach second metaphase (MII) and are 
fertilized, which suggests that the nucleolus is not required for fertilization. 
However, the embryos that originate from enucleolated oocytes never progress 
to the 4-cell stages and show an abnormality of higher chromatin organization in 
both female and male pronuclei. After the reinjecting the nucleolus in the oocytes, 
these oocytes are fertilized and develop to full term. While reinjection of the 
nucleolus at the pronucleus stage can rescue the embryos, it highly reduces the 
rate of blastocyst formation (Ogushi and Saitou, 2010). This data indicates that 
the nucleolus of oocytes is critical for the early step of pronuclear organization.  
 
Ribosome biogenesis in eukaryotic cells starts with the transcription of the 
ribosomal DNA (rDNA) into a 47S (45S in yeast) polycistronic precursor by RNA 
polymerase I in the nucleolus (Fig.1.3). The precursor contains the mature 18S, 
5.8S and 28S rRNA interspersed with non-coding internal transcribed sequences 
ITS1 and ITS2, and is flanked 5’ and 3’ by external transcribed spacers (ETS). 
Hundreds of r-proteins, non-ribosomal proteins, and small nucleolar RNAs 
(snoRNAs) associate with the 47S pre-rRNA, forming the 90S pre-
ribonucleoprotein particle (90S pre-RNP) (Cisterna and Biggiogera, 2010; 





exo- and endonulceolytic ribonucleases within the ITS1, the 90S precursor splits 
into the pre-40S small subunit and the pre-60S large subunit, which further 
become mature 40S and 60S subunits, respectively. The 40S subunit consists of 
the 18S rRNA, while the 60S subunit contains the 5.8S and 28S rRNAs as well 
as the 5S rRNA that is transcribed independently by RNA polymerase III (Eichler 
and Craig, 1994; Venema and Tollervey, 1999). The 40S and 60S subunits are 
then exported from the nucleolus to the cytoplasm, where final maturation takes 
place.  
 
Figure 1.3 Ribosomal biogenesis 
Ribosomal biogenesis occurs in the nucleolus, where the 47S pre-rRNA is 
transcribed by RNA polymerase I. The 47S pre-rRNA is then being processed by 
ribosomal proteins, ribonucleoproteins, and ribosomal proteins to generate the 
mature 28S, 18S, and 5.8S rRNA. The 18S rRNA will be incorporated into the 
pre-40S ribosomal subunit, while 28S, 5.8S and 5S rRNA, and ribosomal 
proteins form the pre-60S subunits. The pre-40S and pre-60S subunits transport 
from nucleolus to cytoplasm and then initiate the final maturation.  
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Several studies have used gene-targeting techniques to identify the role of 
nucleolar proteins during early embryogenesis. Most cases have shown defects 
in embryo development when the protein function was disrupted. For instance, in 
mouse mutants for proteins involved in ribosomal rRNA synthesis and processing, 
such as pescadillo-1 (PES-1) (Lerch-Gaggl et al., 2002), RNA polymerase 1 
(Yamamura et al., 2008), SURF6 (Romanova et al., 2006), RBM19 (Zhang et al., 
2008), EMG1 (Ding et al., 2010), WDR36 (Gallenberger et al., 2011), LIN28 
(Vogt et al., 2012) and so on, mutant embryos are arrested at the morula stage. 
For the Tif1a (a gene mediating the processing of rRNA transcription) mutant 
(Yuan et al., 2005), and the S6 (Ribosomal protein S6) mutant (Volarevic et al., 
2006), phenotypes appear after implantation. In addition, knocking out of 
nulceophosmin, a nucleolar protein that processes rRNA and segregates 
chromosome, mutants fail between embryonic day E11.5 and E16.5 (Grisendi et 
al., 2005). Although these mutants die at different developmental time points, 
they all show disruption in the nucleolus and increased cell apoptosis, which 
suggests that nucleolar proteins are important for embryo development.  
 
1.5 Generation and Phenotype of l11Jus1 and l11Jus4 
Mouse chromosome (Mmu Chr) 11 shares significant synteny conservation with 
regions of six different human (Hsa) chromosomes: 22, 7, 2, 5, 1, and 17 (Boles 
et al., 2009). The largest domain of synteny conservation between mouse and 
human occurs on distal Mmu Chr11, which is entirely syntenic with Hsa chr 17 
(Hentges et al., 2007). The gene-rich domain flanked by Trp53 and Wnt3 in this 
region of synteny conservation contains 2545 gene structures, including 1597 
predicted protein-coding genes, 450 processed RNAs, and 498 pseudogenes 
(Boles et al., 2009).  
 
A large-scale, phenotype-driven ENU (N-ethyl-N-nitrosourea) mutagenesis 
screen targeted to this 34 Mb region of Mmu 11 demonstrated the wide functional 





al., 2003). Functional analysis of 785 total pedigrees from this ENU mutagenesis 
screen resulted in the discovery of a variety of mutant phenotypes, including 
infertility, craniofacial abnormalities, neurological defects, and lethality (Kile et al., 
2003). Subsequent studies detailed the embryonic lethal phenotypes of 45 
mutant lines that fell into 40 complementation groups (Hentges et al., 2006b; Kile 
et al., 2003). Resequencing efforts led to the identification of causative or 
putatively causative lesions in 31 genes in 17 lethal lines (Boles et al., 2009).  
 
Although many mutations were identified in the sequencing study, the lesions in 
the l11Jus1 and l11Jus4 complementation group have yet to be identified. These 
two mutants survive through implantation but arrest prior to embryonic day (E) 
6.5 (Fig. 1.4) (Hentges et al., 2006b; Kile et al., 2003). Since these two mutants 
fail during this critical window, we undertook a positional cloning strategy to 
identify the causative mutations in this complementation group. We identified that 
both mutant alleles have non-conservative missense mutations in the Notchless 
homolog 1 (Drosophila) gene, Nle1 (Lossie et al., 2012). Moreover, targeted 
disruption of Nle1 in mice (Cormier et al., 2006a) results in an embryonic lethal 
phenotype that is remarkably similar to l11Jus1 and l11Jus4, providing further 
supporting evidence that Nle1 is disrupted in both mutant alleles.  
 
Previous studies have determined that Nle1 is a key regulator in the NOTCH 
pathway (Royet et al., 1998b). NLE1 was first discovered in Drosophila and 
belongs to the WD40 repeat family of proteins. It can either reduce or enhance 
NOTCH activities in a complex manner, depending upon the developmental 
stage and the species. Studies in Drosophila and Xenopus demonstrate that 
NLE1 signals via the canonical NOTCH pathway (Cormier et al., 2006a; Royet et 
al., 1998b). In invertebrates and lower vertebrates, the NOTCH pathway is critical 
for directing cell fate prior to gastrulation, and also plays important but varied 
roles in germ layer boundary formation. At the 4-cell stage in C. elegans, NOTCH 





expression of TBX-37 and TBX-38 (Good et al., 2004). In sea urchins, the 
NOTCH pathway impacts the development and differentiation of the secondary 
mesenchymal cells, which are fated to produce mesodermal cells (Sherwood and 
McClay, 1999, 2001). In contrast, in X. laevis, induction of NOTCH signaling 
leads to an increase in endoderm-specific and a decrease in mesoderm-specific 
markers, while suppression of NOTCH signaling has the opposite consequence 
(Contakos et al., 2005).  
H&E stained sections of implantation sites from the WT and mutant embryos  
 
 
1.6 NOTCHLESS in the ribosomal biogenesis pathway  
For the species that lack NOTCH signaling, such as yeast and plants, NLE1 is 
integral to ribosomal biogenesis (Chantha et al., 2007b; de la Cruz et al., 2005a; 
Matton and Chantha, 2007). NLE1 is structurally similar to a protein called 
WDR12, in that they both contain an Nle domain and WD40 repeats (Nal et al., 
2002). In yeast, the WDR12 homolog Ytm1 and the NLE1 homolog Rsa4 both 
interact with the AAA+-ATPase Rea1 in directing rRNA processing (Bassler et al., 
2010; Bottcher et al., 2009). Rea1 is a conserved pre-ribosomal factor that was 
identified as a component of the pre-60S particle located in the nucleoplasm 
(Galani et al., 2004; Nissan et al., 2004). Rea1 is required for the formation of 
60S and processing of ITS2, being specifically involved in a late step generating 





the mature 5.8S rRNA from the 7S pre-rRNA (Galani et al., 2004). Electron 
microscopy showed that Rea1 contains two major domains, an AAA motor 
domain that binds to the pre-60S particles, and a long flexible tail harboring a 
metal ion-dependent adhesion site (MIDAS) (Bottcher et al., 2009). The MIDAS 
of Rea1 directly but sequentially contacts the N-terminal NLE domain of Ytm1 
and Rsa4 during 60S subunit biogenesis; therefore, the NLE is also called 
MIDAS interacting domain (MIDO) (Bassler et al., 2010; Bottcher et al., 2009). A 
conserved glutamate in the MIDO has been found to be essential for interacting 
with MIDAS. Disruptions of both yeast NLE1 and WDR12 lead to the blocking of 
the processing from 35/27S precursor rRNA to the mature 25S rRNA and 5.8S 
rRNA (in mammal, corresponding to 36/32S pre-rRNA to 28S rRNA and 5.8S 
rRNA) (Bassler et al., 2010). In addition, mutating the conserved glutamate in this 
domain in yeast WDR12 causes an early block at the transition of 60S from the 
nucleolus to the nucleoplasm (Bassler et al., 2010). The glutamate mutation in 
yeast NLE1 leads to inhibition of exporting the pre-60S particles from the 
nucleoplasm to the cytoplasm (Bottcher et al., 2009). Because all these proteins 
are conserved across species, it is possible that in mouse, the Rea1 homolog 
(MDN1) drives a similar interaction between WDR12 and NLE1 during 60S 
ribosomal biogenesis.   
 
1.7 P53 Regulation 
The tumor suppressor gene p53, which governs the regulation of cell proliferation 
and apoptosis (Levine and Oren, 2009), also plays an important role in the 
normal development. The function of p53 and the p53 family members (p63 and 
p73) is mostly determined by cell context, i.e., the cell’s physiological background 
(Vousden and Lane, 2007). For example, when cells are under stress caused by 
radiation, hypoxia, metabolite shortages, oncogene dysregulation or viral 
infections, the p53 clan members, and in particular p53 itself, can be activated to 
restrain damaged cells from transformating by inducing cell cycle arrest, 





Oren, 2009; Vousden and Lane, 2007). In contrast, lack of proper function of p53 
leads to cancer progression (Molchadsky et al., 2010).  
 
P63 and p73 belong to the p53 clan family. They play similar but slightly different 
roles than p53. P63 is usually overproduced in tumor cells, while most of these 
over-produced p63 are the isoforms that are able to bind DNA, but incapable of 
transactivation because they do not contain the transactivation domain (Candi et 
al., 2007). Therefore, p63 is thought to act in a dominant negative way toward 
transactivation. Like p53, p63 can direct cells to apoptosis in response to DNA 
damaging (Gressner et al., 2005). Similarly, p73 is a transcriptional factor 
activated by damaging stress and can induce many of the classical p53 target 
genes (e.g., p21, Puma, Bax) as well as p53 itself (Wang and El-Deiry, 2006).   
 
Since the p53 response can lead to cell death, it is crucial to maintain appropriate 
p53 activity levels. One of the major ways in which p53 is regulated is through a 
rapid protein turnover. In normal cells, p53 is expressed at very low levels with a 
short half life (Shadfan et al., 2012). The p53 protein is constantly produced and 
rapidly degraded by ubiquitylation mediated by MDM2, allowing the quick 
removal or buildup of p53. P53 undergoes various post-translational 
modifications, including phosphorylation, acetylation, methylation, and 
ubiquitination (Appella and Anderson, 2001; Carr et al., 2012; Dai and Gu, 2010).  
 
After cellular stress, p53 is activated and stabilized through acetylation and 
phosphorylation, thereby inducing cell cycle arrest or apoptosis. The reversible 
acetylation of lysine residues is widely accepted for activating p53 function (Tang 
et al., 2008b). Many studies have described how DNA damage can induce p53 
acetylation either through activating of acetyltransferases or by recruitment of 
those acetyltransferases by phosphorylating p53 (Jenkins et al., 2012; Meek and 
Anderson, 2009; Sykes et al., 2006). P300 and CBP are the two highly related 





on the C-terminal of p53. These six lysines are K367, K369, K370, K378, K379, 
and K383 in mouse, equivalent to the human K370, K372, K373, K381, K382, 
and K386, respectively (Feng et al., 2005; Krummel et al., 2005). The same 
lysine residues are targeted by MDM2 for ubiquitylation. Since acetylation and 
ubiquitylation of the same lysine are mutually exclusive, acetylation on p53 leads 
to blocking of ubiquitylation and thereby suppressing the degradation of p53 by 
MDM2 (Li et al., 2002). Acetylation of these residues prevents p53 translocation 
from the nucleus and inhibits subsequent degradation (Tang et al., 2008b). 
Acetylation also increases the DNA-binding ability of p53, and consequently 
activates the transcription of its target genes, leading to the induction of cell cycle 
arrest or apoptosis, depending on the cell types and the nature of cellular stress 
(Gu and Roeder, 1997; Luo et al., 2004; Wang et al., 2003).     
 
An active p53 can be induced by cellular stress. One of the major types of stress 
responses that initiates a p53 response is DNA damage (Shadfan et al., 2012). 
After DNA damage, proteins are recruited to the damage site and activate the 
p53 pathway that leads to cell cycle arrest in order to repair the damage. If the 
damage cannot be reversed, the cell will undergo permanent cell cycle arrest or 
programmed cell death (apoptosis) (Molchadsky et al., 2010). One of the key 
activators in this p53 activation is Ataxia Telangiectasia Mutated (ATM), which 
acts on the p53 inhibitor MDM2 (Chun and Gatti, 2004; Maya et al., 2001). ATM 
kinase directly phosphorylates MDM2 at S395, which changes the activity of 
MDM2 ligase to prevent p53 degradation and export (Mayo and Donner, 2001). 
Another kinase, DNA-PK (DNA-activated Protein Kinase), also phosphorylates 
MDM2 at its p53-binding domain that leads to reduced affinity of p53 and MDM2 
(Mayo et al., 1997). Therefore, the amount of stabilized p53 is increased.  
 
Another type of cellular stress that activates p53 is ribosomal stress (Deisenroth 
and Zhang, 2011). Several studies link p53 activation to the interaction between 





(Daftuar et al., 2013; Dai and Lu, 2004; Jin et al., 2004; Lohrum et al., 2003; 
Zhang et al., 2003; Zhu et al., 2009). These studies determined that during mis-
regulation of ribosomal biogenesis, ribosomal proteins can activate p53 by 
binding to and inhibiting MDM2. Moreover, studies have shown that ribosomal 
stress induces degradation of MDMX (also known as MDM4) (Gilkes et al., 2006). 
MDM2 and MDMX are binding partners and have been shown to regulate p53 
activity as a complex (Joseph et al., 2010). When cells are under ribosomal 
stress, ribosomal protein L11 promotes MDMX degradation by binding to MDM2 
and causes p53 activation (Gilkes and Chen, 2007; Gilkes et al., 2006). 5S rRNA 
has been found to stabilize MDMX, which may be important to control the activity 
of MDMX under normal cell conditions (Li and Gu, 2011).  
 
1.8 Objective  
According to the American Pregnancy Association, miscarriage is the most 
common type of pregnancy loss, and 15-20% of clinically recognized 
pregnancies terminate in miscarriage (Rai and Regan, 2006). Given the high 
number of miscarriage occur in human population, further research in embryonic 
development is necessary. The long-term goal of my research is to understand 
how genetic and epigenetic events work together to regulate early mammalian 
development. This information can be used to develop therapeutic strategies to 
reduce the incidence of miscarriage in the U.S. The phenotype of the Nle1 
mutant mimics early miscarriage. Mutant animals survive through implantation 
but fail prior to gastrulation. NLE1 is a member of the WD40-repeat protein family, 
and is thought to signal via the canonical Notch pathway. In invertebrates and 
lower vertebrates, the Notch pathway directs cell fate prior to gastrulation. 
However, gene-targeting studies demonstrate that Notch signaling is dispensable 
for gastrulation in mice. Interestingly, reports in yeast and plants (which lack 
NOTCH signaling) demonstrate a role for NLE1 in ribosomal biogenesis. In 
addition, previous studies in our laboratory have demonstrated that Nle1-/- 





expression, but do show mis-expression of Cdkn1a and several members of the 
Wnt pathway, suggesting that NLE1 interacts with other signaling pathways prior 
to gastrulation in mammals. Therefore, the objective of my project is to elucidate 
the role(s) of Nle1 during early embryonic development. I hypothesize that prior 
to gastrulation, Nle1 functions in multiple signaling pathways. The rationale is 
that the investigation of the genetic regulatory network of Nle1 would provide 
opportunities for developing enhanced diagnostic strategies and potential 






CHAPTER 2.  IDENTIFICATION OF 129S6/SVEVTAC-SPECIFIC 








The laboratory mouse is the major animal model used for human disease 
research because of its high relevance to human biology and striking genetic 
similarities. Understanding the polymorphisms in the laboratory mouse will 
provide insights into the evolutionary history of the species and increase 
knowledge of the relationship between genotypic and phenotypic differences 
(Guenet, 2005). Polymorphisms are genetic variants arise from spontaneous 
mutations, and by random genetic drift that occur with a population frequency 
greater than 1%, eventual reach steady-state in a population (Schork et al., 
2000). Several types of polymorphisms are found within mammalian genomes, 
including single nucleotide variants (SNVs), insertions and deletions (Indels), 
variable number tandem repeats (VNTRs), copy number variants (CNVs) and 
microsatellite repeats.  
 
Different types of polymorphisms are generally created by different kinds of 
alteration events. For example, SNVs, the most common types of polymorphisms, 
result from a single base substitution. The most common SNV in the mammalian 
genome is a C to T transition, whereby a methylated cytosine is spontaneously 
deaminated to form a thymine base (Miller et al., 2001). Since this change is not 





unless it is under selection, is lost or by chance randomly fixates. SNV variation 
in protein-coding genes and in other functionally constrained regions of the 
genome, such as promoters, enhancers, miRNAs and other non-coding 
sequences contributes significantly to phenotypic variation (Bartel, 2009; Morin 
PA, 2004; Sethupathy et al., 2007). Indels are often, but not always, present in 
highly repetitive sequences (Chen et al., 2009).They are abundantly distributed 
across the genome, but not as common as SNVs (Vali et al., 2008).  Both of 
these types of genetic variations can be used as tools in genotyping, as well as 
discovery of disease- or trait-related genes by directly sequencing SNVs or 
identifying Indels based on size separation or sequence.  
Many mouse polymorphism databases are available, such as the MGI (Mouse 
Genome Informatics) Strains, SNPs & Polymorphisms database 
(http://www.informatics.jax.org/strains_SNPs.shtml) (Blake et al., 2011a) and the 
MPD (Mouse Phenome Database) SNP collection (http://phenome.jax.org/SNP/) 
(Smith JA, 2010). The MGI database provides reference SNV and Indel 
information, as well as the corresponding genotyping assays. SNV queries can 
be based on strain, map position, marker range or associated genes. Currently, 
there are data from 86 mouse strains, but many holes exist in these databases 
and more assays are needed to fill in the blanks.  
 
While conducting a positional cloning project to identify induced variants from an 
N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we detected several 
129S6/SvEvTac polymorphisms in potential candidate genes. This ENU 
mutagenesis screen was performed on C57BL/6J males, which were bred to 
129S6/SvEvTac animals carrying an inversion chromosome for the targeted 
region (Hentges et al., 2006a; Kile et al., 2003). The mouse reference sequence 
is based on C57BL/6J, which is one of the most widely used inbred mouse 
strains for the generation and analysis of transgenic mice and disease models 
(Al-Hasani et al., 2004; Tang et al., 2008a). 129S6/SvEvTac and 129S1/SvImJ 





al., 2010). 129S1/ImJ is one of the 17 additional mouse strains being sequenced 
by the Sanger Center (Turner et al., 2009). However, there is very little 
polymorphism data for 129S6/SvEvTac. As a result, it is important to develop 
SNV and other polymorphism detection assays to help identify 129S6/SvEvTac 
alleles to facilitate genotyping. Here we provide SNV and insertion/deletion (Indel) 
information for 7 genes located on chromosome 11 between these three 
























We isolated genomic DNA from mouse tail biopsies from 129S6/SvEvTac and 
C57BL/6J animals; 129S1/SvImJ DNA was purchased from the Jackson 
Laboratory. Exons from each gene were sequenced individually. Each 600-800 
bp PCR amplicon contained one or more exons plus upstream and downstream 
flanking sequence. Exons larger than 800 bp were sequenced by multiple 
overlapping sequencing reactions. All amplicons were sequenced in both 
directions using Big Dye v3.1 chemistry (Applied Biosystems, Foster City, CA). 
Primers are listed in Table 2.1. 
 
We analyzed the data using Sequencher 4.9 (Gene Codes, Ann Arbor, MI) to 
identify polymorphisms among the various strains used in this study. The 
sequences from different samples were assembled automatically and then 
entered into a BLAT search against the UCSC genome database 
(http://genome.ucsc.edu/cgi-bin/hgBlat?command=start) (Kent, 2002)(NCBI Build 
37 (Mm11_95772_37)) to obtain the cDNA and genomic DNA sequences. All 
sequences (including cDNA and genomic regions) were assembled with our 
sequencing data into a contig that spanned one individual exon. The contig was 
scanned for any polymorphisms using features of the Sequencher program. 
Once a variation was identified, we checked the chromatogram manually to 
distinguish true polymorphisms from sequencing errors. All SNVs and other 
polymorphisms were compared with SNV information from the MGI database 
(dbSNV Build 128) to pinpoint SNVs within the contig and identify unique 
polymorphisms. Exon or intron positions were determined using the UCSC 
genome database (http://genome.ucsc.edu/) (Fujita et al., 2011). We compiled all 
polymorphisms into tables containing gene location, nucleotide number, local 








Table 2.1 Primers used for this study 
Gene-exon Forward sequence Reverse sequence Tm Size 
Mettl16-E1F TTCTCCATCCGCTAACCTAAGAAG TCAACAGATGTCTCCCACCTAGAC 60 624 
Mettl16-E2F GGCACTAAATATGCTGGTTTCCTC AATCACACAAAGCACAGTCCTAGC 60 468 
Mettl16-E3F GAACGCTGTACCATGGAGCTATAC ACTTCTCAATGATACCTGCAGCC 60 1081 
Mettl16-E4F GTGTATCTGCTGTTGTGCTGAATG TTCTTCCTTCCACGCTTCTCTAAC 60 553 
Mettl16-
E5/6F 
CTCTGAGTTATGTGTGAAATGGGC CCCAAATCTCAGGGCAATCTATAC 60 731 
Mettl16-E7F TCCAACTCTCCTTCATGGTTTATG CTGAACAACTTGTGCTAACACTGC 60 616 
Mettl16-
E8/9F 
GATAAACTTGATGCGTCTCCATTG CTCCGGAAGCCTTAATAACTGAAC 60 504 
Mettl16-E10F ACCATGGGCTAATCCAAGTTAATG CAGAACTAGGTGGAGGTCTTCGAG 60 490 
Mettl16-E11F CTCCCACTGGCTGTGTGTTC CTGAGATGGCTGGTAGTCTGTTTC 60 599 




Mettl16-E14F CTCTACATGCCTTCAGGGTCTATG AAGCTGCTATACCCAAATTTCGAC 60 928 
Mettl16-E15F AAAGAGCAACAGGAGTTAGCAGC GGTCTACCGAAGCTTATCACACAA 60 353 
Mettl16-E16F TCAATAAAGGCCTGAGATTCCTTC CAACAGCAGTGGGCTTAGTGTTAG 60 552 
Evi2aE1F CACTAAAGATGCCATCATGTAATTT
CC 
TCAAGACCTTCCTCATCCTGATTT 62 626 
Evi2aE2aF CCCTGACTGTCTCAGCCTTCTAAT TTAACAGGCTGCACTTGAGATAGC 62 866 
Evi2aE2bF CCATGTTCTCCTTTCCTTCAAGAT GGTGTTCTCCTCACAGACTTCCTT 62 825 
Evi2aE2cF GCCTCAGGTTCCAGTAATCAGAAT ATTCAGACAGAGGTCATTCACTGC 62 845 
Evi2aE2dF AGAGAAAGCACGAAGAAGGAACTG GTGTATGCCTAGTTCCCAAGGAAG 62 887 
Pmsd11E1F ACGGGGCAGAGAGACTACAACT ACAGTGAGTCAGCAGCACCATAG 62 342 
Pmsd11E2F TTCATTTTCTTTTCTTAGTGAAACGT
G 
AAAACAGGACTTTCCCTCACCTAT 62 320 
Pmsd11E3F CCATATGCTTGTGTGGAGCTTAAA CATCCTTCCACACACTACCACAGT 62 401 
Pmsd11E4F CTATGGACTGTGTGAACAACATGG ACACTCCCATAACTGGAAGCACTA 62 314 
Pmsd11E5F TCAGTTGTTGTGTTGAACTTGATGT AGCAGGACTTTACCGTGACAAAT 62 375 
Pmsd11E6F GGGCTGGGTATGACAGCTCA GAGGTGAGCAGTAAGAAAGCATGTC 62 400 
Pmsd11E7F TAGGAACTGGCTTGTGACTTGTG CTCTGACCACCACACTCTGTATCA 62 450 
Pmsd11E8F TTTTGTTTTGCAGCCCAGAAG ATTAAGGGAGGAAAACAGGGATG 62 200 
Pmsd11E9F TGATGGTGAGGACAGGCTGTTTAT CCTCGAGCTCAGGGATCTGC 62 311 
Pmsd11E10F AGCTTGGTCATGAGAGAGTTTCCT GGCCTCTTACCAGACAGACATACC 62 430 
Pmsd11E11/
12F 
AGGCAGAGCAGAGGACAGTAAGAT CATCTCTCTCCACTCCCTTACACA 62 574 
Pmsd11E13F TAAATAGAAAGGCGTGCTGTGAAA CCAACTCTGCAAGAGAAGACAGAG 62 376 
Pmsd11E14F AGAAGCTGACATAGGTGAGTGCTG CAATTCTGAAGAGGAGGAGAGGTG 62 500 
Cct6bE1F TCAGTTCTTCCTGATTCACCACTC CGCACAAGGCTAACAGTTTCTATT 62 545 
Cct6bE2F TAAGGTCATCCGGGAGAACTAATC GCACTGCATCTAATACCTGAATCC 62 415 
Cct6bE3F GAAGCAAAGACTTTCATACAATGTT
CA 
ACGGGAGCTTTCTCTTTAACCTTT 62 552 
Cct6bE4F ACACATTTATGTTAGTGCCGTTGC TGAATTGTAAATGCTTGCCTTGTT 62 689 
Cct6bE5F TATATTGGTGTTCCTCAGCTCTGC AGGGAGATCTTCAAGTCAGCATTT 62 587 
Cct6bE6F TTTGAGCCGTGTAACTTAGAGAATA
A 
ACTCATGCACATACACACTCACAA 62 440 
Cct6bE7F TTACAAATACGAGCCATCATGTCC CTTACAAATGTCCACACAGTGCAA 62 549 
Cct6bE8F GACTTTAGACCTCCCTTGCTTCAG CCCTGACTGTCCTAGAACTCACAA 62 552 
Cct6bE9F ATAACCAAAGTGAGCATGGCATAA AAACTGTTCTTCATGGAAACACTCAC 62 158 
Cct6bE10F TTGAACTGCCTTTGTAACTCAACC GGCAGCCTACCTTATCTCTCCTCT 60 621 
Cct6bE11F GAAGAGGGCATTACATCCCATTAC CAAGTCCTTCATTTCCCACAAGTA 62 658 
Cct6bE12F TAGGTTGGGAATGGGATTCTTCTA CTTGATGGTAATGGACTGAACCTG 62 469 





Table 2.1 Continued.  
Cct6bE14F GGTGAGGGTGCTTCCTTGATAATA AAGCTGGAATTGACTGGGATACTC 62 535 
RfflE1F CCACACCTGTCCCATGAAAGT GGCCCTACTTCCCTCTGAGTCT 62 362 
RfflE2F TGGTACTAACAGATTATCACTAACT
TGC 
AGGTGTGTGCTTTAGCTACTCG 62 393 
RfflE3F CGATATTTGGAACACTCACTCTGG GGGTCTATGCTGCTGTCTGAGTT 62 529 
RfflE4F CTGTGTGTATCATCTCTGGCTGTG ACTGGACTCAAGGACTTCAGGACT 62 412 
RfflE5F CTGTGTGTATCATCTCTGGCTGTG ACTGGACTCAAGGACTTCAGGACT 62 412 
RfflE6F GTGTGTGGCTGTCTGCATAAAGTA AACTGTGTATTCAATGCCTGTTCC 62 484 
RfflE7pcrF CTCCACATGACTTCTCTGAACACA GCAAGGGCAATACCTGACTCTACT 62 332 
RfflE8aF TGATCTGAGAGTACCAGACTCAAA
CC 
GGATCTTAGGACAGGAGAGACTGG 62 663 
RfflE8bpcrF ACGCATGAACGAATGTCCTATCT GATCCAAACTCTGACCTGAGGAAT 62 586 
RfflE8cpcrF CCAGTCTCTCCTGTCCTAAGATCC AGGACCAGAAGACAAAGACAAAGC 62 488 
RfflE8dpcrF GGCCAATAGTATTCCTCAGGTCAG TTCTCAGCTGTGTCAGTGGTGTAA 62 569 
Ap2b1-E1/2 GGGCTTCTTAACCTTACAAGCAAA ATTTACAGCCTTGCCCAAACTAGA 62 1144 
Ap2b1-E3 CCTTGAAGCAAGTTGCAGTTCTTA CCTTAGTTTGTAAGCCCACACTCA 62 570 
Ap2b1-E4 TAAAGTAGGGTCTGTGTGGCCTTT TCTCAAGACATTGGTGCTATGTTG 60 500 
Ap2b1-E5 GGAAGCCAACACTGTCATCTGTAT ACAGCATGTCCACTCTCTATCAGC 62 527 
Ap2b1-E6 AAAGAATGCCATGAGAGATTGGAT TACCCTGTAGTCGTGTCTCCAAGA 62 479 
Ap2b1-E7 CTTGGAAGCTGTCTATGCTGTCAT AATACGCTAGGGATAGCAATGTCC 62 513 
Ap2b1-E8F CAAGAAGGAAACTGGTGTGAGTGT AGGGCACCAGTCTATAAAGCAATC 62 590 
Ap2b1-
E9/10F 
CAGGCAGAAAGACTGACTTGATTT CTTCTGGCCTACACAGGTAGTTGA 62 810 
Ap2b1-E11F TAGCAGAGTCAGTGCCTGTCTGA TTCAAAGTGCCTTACTTATACGTTTCC 62 292 
Ap2b1-E12F CTTGGAATCCCTTGTGTATGGTTT TAAGCGCTGCAGCTTTGTTATCTA 62 429 
Ap2b1-
E13AF 
GCATGGTCAATGATTGCTTTGTA CTGCAACAGATCAAGAAGAGGTGT 62 950 
Ap2b1-
E13BF 
TTCTCAAGAAGCCATCAGAAACAC AGTCACCCACAGATACCAGATTCA 62 992 
Ap2b1-
E13CF 
GCCTCAAAGCAGATTCTGTTCAAT TTGAGATTTCAGGCCTGTGCTA 62 1000 
Ap2b1-
E13DF 
ATACTCTGACAAGCGACTTCAGGA TGAGAGCTCAGAACTGGCAAA 62 945 
Ap2b1-
E13D2F 
CCTTTCATAACAGGTCACAACCAG TGAGAGCTCAGAACTGGCAAA 62 558 
Ap2b1-E14R CCCTGCCCATATCAATCTATGTTT AAAGAAGCTCTTCAGAGCAGCAAG 62 596 
Ap2b1-E15R TCTCCTTCCATGTGTAGATTCTGG CGGCCAACATGATAAACCTATACA 62 564 
Ap2b1-E16R TTCACTCCCACTGCTCAGTTC AGTCAAGACTGGAGGTTCCATTTC 62 507 
Ap2b1-E17R GACAAAGCCTCTAAAGCACGTGTA ACGAGGCCCAAACTCAAATAGTTA 62 540 
Ap2b1-E18R AAAGAAGCCAATTGCTCATAGACTT
T 
TTTGTCCTGTTCTCCAGAGTCAAG 62 541 
Ap2b1-E19R TAGATTGTGTTGGAGCAGGTCAA CTACCACAATTCTCCGCATGATAC 62 504 
Ap2b1-E20R ACCTACAGACTGAGGATCATTGG TGAGATTTGAGGTGGCAGAGTAAG 62 527 
Ap2b1-E21R CTCTTAACTGCATGCTTTCTTCCA TAGGGCTGTGCCTTAGAGAGATTT 62 427 
Ap2b1-E22R CTGCCTGTATCAGAAGAAGCTCTG GGGAAACCTATAGGGTGGAGACTT 58 1187 
Ap2b1-
E22AR 
AGTCCTGTGTTGCAATCATGAAAT GAGGCAGGGTCTCAACTATGAAGT 62 287 
Ap2b1-
E23AR 
GCCACACAAGCTGTAGGTAGACAT AAGACTGTGTTTGATGAGGGTCAG 60 756 
Ap2b1-
E23BR 
TCTTGTGCTGACATTAGCATTCAC ACCAGTCTCAGCTCTGCTACTCAA 62 853 
Ap2b1-
E23CR 
GAACACTGAGTAGAAAGGGCGACT CAGTGAGCTGACAGACAGTGAGAA 62 833 
Ap2b1-
E23DR 
TGAGTAGCAGAGCTGAGACTGGTT GAACTTGGTCAACTTGTCTTTCCA 62 804 
Ap2b1-
E23ER 






We analyzed Nle1, Mettl16, Evi2a, Psmd11, Cct6d, Rffl and Ap2b1 on mouse 
chromosome 11. Chromatographs for representative SNVs within each locus are 
shown (Figure 2.1). We only detected differences between C57BL/6J and 
129S6/SvEvTac in Mettl16 and Ap2b1. However, we summarized SNV 
information for sequenced genes.  
 
We identified 21 new polymorphisms and compiled a list of all of the 
polymorphisms found to date within the Nle1 locus (MGI dbSNV Build 128) 
(Table 2.2) (Blake et al., 2011b). Nle1 is transcribed from the Crick strand, and 
variances are ordered in reference to Nle1, not the chromosome. The nucleotide 
position is noted in column one (NCBI Build 37) and the location within Nle1 in 
column two. Variances detected within exons are designated as synonymous (S) 
or non-synonymous (N). Variances reported in the MGI database, but not found 
in our sequencing studies are depicted by gray cells, and SNV IDs for previously 







Figure 2.1 Represnetative chromatographs 
Mettl16 (A), Evi2a (B), Psmd11 (C), Cct6b (D), Rffl (E) and Ap2b1(F). The SNV 
in each sequence is marked in black box. We detected no polymorphisms among 
129S6/SvEvTac, 129S1/SvImJ and C57BL/6J in Evi2a, Psmd11, Cct6b or Rffl. 
These sites contain known polymorphisms within different inbred mouse strains. 
 
We included known variants in the reference strain (C57BL/6J), as well as those 
found in the 129S6/SvImJ, C3H/HeJ, NOD and CzechII strains, and the strains 
that we sequenced (l11Jus1, l11Jus4, C57BL/6J, 129S6/SvEvTac, and 
C3HeB/FeJ). In total, there are 73 variances across the Nle1 locus, including 5’ 
and 3’ UTR sequences. We saw no discordance between the C57BL/6J 
sequences and the reference sequence. We discovered 9 new indels; 
129S6/SvEvTac and C3HeB/FeJ had identical sequences across these regions, 
while C57BL/6J, l11Jus1 and l11Jus4 segregated together. cDNA comparison 





has a single nucleotide deletion in the 3’UTR sequence (Carninci and 
Hayashizaki, 1999). All polymorphisms identified in the 129S6/SvEvTac and 
C3HeB/FeJ strains are new. We identified five new expressed SNVs across the 
gene and one expressed indel in the 3’UTR. One previously reported expressed 
SNV (rs28209059) is a missense mutation (C 912 G; Table 2.2) in the 
129S6/SvImJ and C3J/HeJ strains. This results in a neutral amino acid 
substitution (N 291 K) (Livingstone and Barton, 1993) within exon 8, which does 




























































































   
   
   
   
   




















   
   
   
   



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The RefSeq annotated transcript for Methyltransferase like 16 (Mettl16), the most 
proximal gene in the group, is expressed from the Watson strand and contains 
10 exons; 4 additional exons are predicted based on Ensembl annotations. We 
sequenced all 14 exons and identified 18 variants (Table 2.3). Although 
C57BL/6J is the mouse reference sequence, the dbSNV database lacks 
significant C57BL/6J information. Red lettering denotes the variant, grey boxes 
indicate new dbSNV information and bold lettering indicates novel sequence 
variants between C57BL/6J and 129S6/SvEvTac; all new variants have been 
deposited into the dbSNV database.  
 
We identified two new SNVs (10 and 18) and indels (11 and 14) within Mettl16. 
SNV 10 is a T to G transversion in intron 5, while SNV 18 is a G to C 
transversion located in intron 8. Indel 11 is a 3 bp insertion located within a string 
of Ts, and it is therefore impossible to determine the exact insertion site. Indel 14 
is a 12 bp deletion in 129S6/SvEvTac. We confirmed the C57BL/6J genotype for 
polymorphisms 13, 16 and 17, and updated the dbSNV database for 13 
additional C57BL/6J and all 16 129S6/SvEvTac alleles. Within the Mettl16 locus, 
129S6/SvEvTac and 129S6/SvImJ are concordant for all variants tested with 
both strains. Notably, 6 SNVs (10, 13, and 15-18) and 2 indels (11 and 14) differ 































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   





































































































































































































































































































Ecotropic viral integration site 2A (Evi2a) is expressed from the Crick strand and 
contains two exons (Table 2.4). Table 2.3 is organized the same as Table 2.2, 
with the following exceptions: amino acid changes are found in column 3 and the 
remaining column numbers are shifted. We designed 5 amplicons for sequencing 
Evi2a, as exon 2 spans 2,058 bp. We confirmed the 16 SNVs in the region and 
did not identify any additional alleles. However, we added genotyping information 
for C57BL/6J for all SNVs. Three SNVs (4 – 6) are located in exon 2; SNVs 4 
and 5 cause missense changes (M), while SNV 6 is a silent variant (S).  
 
Proteasome 26non-ATPase subunit 11 (Psmd11) codes from the Watson strand 
and contains 14 exons (Table 2.5). Table 2.4 has the same organization as Table 
2.3. We designed 13 amplicons for sequencing. Exons 11 and 12 were amplified 
from one PCR product. We confirmed the 4 SNVs in the region and did not 
identify any additional alleles. However, we added genotyping information for 
C57BL/6J for all SNVs. SNV 2 causes a silent variant in exon 3.  
 
Chaperonin containing Tcp1, subunit 6b (zeta) (Cct6b) is expressed from the 
Crick strand and contains 14 exons (Table 2.6). Table 5 has the same 
organization as Table 2. We sequenced each exon and confirmed 9 SNVs within 
this locus. SNV 1 is located downstream to Cct6b, while SNVs 2 and 3 are within 
the 3’UTR and should be identified from mRNA. Although we did not identify any 










































   
   
   
   
   














































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
















































































































































































































































































































































































































































































































































































































































































































































































































































Ring finger and FYVE like domain containing (Rffl) is expressed from the Crick 
strand, contains 11 exons and produces 5 alternatively spliced products (Table 
2.7). Table 2.7 is organized exactly the same as Table 2.3. We designed 13 
amplicons for sequence analysis of Rffl; three span exon 11. To reduce 
complexity, we incorporated all splice variants into a single transcript. RefSeq 
NM_026097.3 contains exons 5-7 and 9-11. RefSeq NM_001164570.1 contains 
exons 2, 4, and 6 – 11. RefSeq NM_001007465.3 contains exons 1 and 6 – 11. 
RefSeq NM_001164569.1 contains exons 1, 2 and 6 – 11. RefSeq 
NM_001164571.1 contains exons 1, 6, 7 and 9 – 11. We confirmed 10 SNVs for 
this locus and found no variants between C56BL/6J and 129S6/SvEvTac. SNVs 
9 and 10 are within the 5’UTR of exons 4 and 2, respectively. SNV 8 is a 
missense variant in exon 6, while SNVs 6 and 4 are silent changes in exons 11 
and 8, respectively. SNVs 1-3 are located in the 3’UTR of Rffl. SNV 8 causes an 
Ala to Thr missense change at amino acid positions 90 (NM_001164569.1), 69 
(NM_001164570.1) and 55 (NM_026097.3, NM_001007465.3 and 
NM_001164571.1) depending upon the RefSeq. 
 
Adaptor-related protein complex 2, beta 1 (Ap2b1) is expressed from the Watson 
strand and contains 22 exons (RefSeq NM_001035854.2) (Table 2.8). Table 2.8 
is organized exactly the same as Table 2.3. We designed 30 amplicons; 6 are 
necessary to span exon 22, 5 are necessary to span exon 12, while exons 8 and 
9 are amplified from a single PCR reaction. We identified 80 SNVs and 4 Indels; 
19 of the SNVs (28 – 32, 36, 37, 41 – 48, 50, 65, 66 and 84) and all Indels (4, 12, 
27 and 80) are novel. SNVs 1-3 are located upstream of the transcriptional start 
site of the two RefSeq genes (NM_001035854.2 and NM_027915.3), but within 
the 5’UTR of the predicted Ensembl transcripts (ENSMUST00000018875). 
Variant 4 (a 6 bp insertion) is located within the 5’UTR of exon 1. The remaining 
3 indels (12, 27 and 80) are located in introns 3, 10 and the 3’UTR, respectively. 
SNV 32 causes a silent change in exon 11. The remaining novel SNVs are 













































































































































































































































































































































































































































































































































   
   
   
   
   
















































































to missense variants (F490L and A602T) in exons 11 and 14, respectively. 
Additional expressed polymorphisms include exons 4, 7, 12, 13, 14, 17 and 20. 
We identified 5 variants between 129S6/SvEvTac and 129S1/SvImJ (blue boxes, 
16, 33, 53, 60 and 82) and 46 differences between 129S6/SvEvTac and 
C57BL/6J (yellow boxes). Notably, SNV 33 leads to a missense variant between 
129S6/SvEvTac and 129S1/SvImJ that could account for differences between 
these two distinct 129 strains.  
 
The polymorphisms located in these 7 genes between 129S6/SvEvTac and 
C57BL/6J strain are summarized in Table 2.9. In total, we identified 15 Indels 
and 181 SNVs in all 7 genes; we are the first to report 44 of these SNVs and all 
Indels. Regarding our analyses, it becomes clear that the major distinctions 
between the 129S6/SvEvTac and C57BL/6J strains lie within Ap2b1, Nle1 and 
Mettl16, while the variations between 129S6/SvEvTac and 129S1/SvImJ lie in 
Ap2b1 and Nle1. This suggests that the remaining four genes might be more 
highly conserved among the 129S6/SvEvTac, 129S1/SvImJ and C57BL/6J 
strains.  
 
We converted the current dbSNV information within this region into a heatmap 
that represents the polymorphism density across the region (Figure 2.2). Red 
areas contain more variants than yellow segments. It is clear that the 7 target 
genes all map to regions that contain high or intermediate numbers of SNVs. 
Interestingly, there are two blocks with a low SNV density. The first lies between 
Mettl16 and Evi2a while the second falls between Evi2a and Psmd11. Based on 
the SNV density, we predict that these two regions contain elements under 











































   
   
   
   
   



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.2 Density map of polymorphisms located in the domain of study 
The heatmap represent current dbSNV information across this region. Red 
indicates highest amount of SNVs and yellow stands for lowest amount. The 7 
genes in this study are marked on the heatmap based on their chromosome 
locations and gene sizes. Genetic variations including SNVs and Indel identified 
in this study are shown by black lines. Each black line correlates with the number 
of polymorphisms within a 10kb domain; longer lines signify increased 




















In order to identify the mutations generated from an N-ethyl-N-nitrosourea (ENU) 
mutagenesis screen, we detected several 129S6/SvEvTac polymorphisms in the 
7 genes discussed in the results. We found no non-synonymous mutations 
Ap2b1, Cct6b, Suz12, Rffl, Evi2a, and Psmd11. However, we identified a T 1184 
G transversion (I 395 S missense mutation) in l11Jus1 heterozygotes in exon 10 
of Nle1 (Table 2.2). This non-conservative substitution replaces an aliphatic, 
hydrophobic amino acid with a polar residue, which likely disrupts functionality 
(Livingstone and Barton, 1993). Subsequent mutation detection efforts resulted in 
the identification of a second missense mutation (T 484 C transition; S 162 P 
missense mutation) in exon 5 of Nle1 for the l11Jus4 allele (Table 2.2). This non-
conservative amino acid substitution has a high probability to alter protein 
function, as serines easily form hydrogen bonds with polar substrates, while 
prolines are rarely found in active sites (Livingstone and Barton, 1993). In 
addition, we detected an endogenous C57BL/6J non-synonymous SNP (A 535 G 
transition; I 179 V) in exon 6 (Table 2.2). This well-documented SNP (rs2820949) 
leads to a very conservative amino acid substitution (Livingstone and Barton, 
1993). Both mutants share the endogenous mutation, indicating that l11Jus1 and 
l11Jus4 homozygotes harbor two coding changes in Nle1–an ENU-induced allele 
and an endogenous C57BL/6J missense mutation.   
  
The 7 genes in this study span a 6.8 Mb domain that contains a total of 154 
genes, 9 miRNAs and 5 snoRNAs. We concentrated our efforts on genes that 
are expressed during pre-implantation development or in gametes. The Evi2a 
locus, which is adjacent to Evi2b, resides within intron 33 of the Nf1 gene. 
Although the function of Evi2a is unknown, the locus demarcates the boundary 
between the two conserved regions, as it contains a high number of 
polymorphisms in a relatively small genomic region. We identified 16 genetic 
variants within the 4kb Evi2a locus, while the average number of variants 





129S1/SvImJ are concordant for all variants of Evi2a, this gene could be crucial 
for the divergence of other mouse strains. Alternatively, polymorphisms within 
this intron could be important for Nf1 gene regulation. Consistent with this 
hypothesis, EVI2A is upregulated in malignant peripheral nerve sheath tumors in 
Neurofibramatosis patients harboring microdeletions within the NF1 locus 
(Pasmant et al., 2011). The dbSNV database indicates that high levels of allelic 
variants are present in the distal end of the 6.8Mb domain that overlaps with 
Cct6b, Rffl and Ap2b1. This is consistent with our results, as we sequenced 84 
variants within this locus.  
 
The 129 strain is commonly used for knockout and other genetic manipulation 
studies because of the efficiency of obtaining ES cells that colonize to the 
germline. (te Riele et al., 1992). This strain originated in 1928 and has diverged 
into more than 15 substrains. Different breeding strategies used in the past 
resulted in phenotypic and genetic diversity among these substrains (Simpson et 
al., 1997). In this report, we sequenced the 129S6/SvEvTac strain that has been 
maintained since 1992 at Taconic. According to Simpson et al., (1997), the origin 
of 129S6/SvEvTac can be traced back to the breeding of the “Steel” substrains, 
which resulted from the outcross of the 129/Sv strain to C3HeB/FeJ followed by 
12-14 generations of backcrossing to the parental 129/Sv line. The resulting mice, 
termed 129/SvEv, were distributed to Martin Evans and were maintained by 
selection for the SteelJ allele. The 129/SvEv strains underwent further genetic 
manipulations to produce 129/SvEvBrd and 129/SvEv-Gpilc. Taconic crossed 
129/SvEvBrd and 129/SvEv-Gpilc to generate 129S6/SvEvTac. This line has 
been bred as a separate inbred line at Taconic since 1992. 
 
129S1/SvImJ was developed as a control-inbred strain for many of the Steel-
derived strains. (Petkov et al., 2004) Therefore, we included this strain as 
reference to compare the genetic variation between 129S1/SvImJ and 





only gene in this study to contain variants between the 129S1/SvImJ and 
129S6/SvEvTac inbred strains. There are 46 variants between C57BL/6J and 
129S6/SvEvTac, 44 alterations between C57BL/6J and 129S1/SvImJ and 5 
SNVs between 129S6/SvEvTac and 129S1/SvImJ across the gene. 
Polymorphism #33 (rs28210244) is a C1571G transversion in exon 11 that 
causes an F469L amino acid substitution. The remaining variants between the 
two 129 strains lie within introns or in the 3’UTR. 
  
Ap2b1 encodes one of the two large chain components of the clathrin assembly 
protein complex 2. Ap2b1 protein is found on the intracellular domain of 
transmembrane coated vesicles and is important for protein transport (Schmid et 
al., 2006). It is unclear why Nle1 and Ap2b1 contains so many polymorphisms 
and why there are differences between 129S6/SvEvTac and 129S1/SvImJ. It is 
possible that the genetic variations lead to alterations in gene regulation and/or 
protein structure changes that respond to strain-specific factors. However, it is 
equally likely that the high number of polymorphisms between 129S6/SvEvTac 
and 129S1/SvImJ is simply due to random silent mutations.  Most of the 
variances within the Ap2b1 locus (82/84) lead to silent changes or are located 
within non-protein coding regions of the gene (i.e. introns or UTR), which is 
consistent with the latter explanation.   
 
Although there are many variants between C57BL/6J and the 129-derived lines 
in this region of MMU 11, all of the polymorphisms between 129S6/SvEvTac and 
129S1/SvImJ are located within a single gene. The domain proximal to Ap2b1 
contains no variants between the two 129 strains. Regions of conservation 
suggest sequences critical for function, i.e. gene variation is not functionally 
tolerated. Phylogenetic studies of 9 different 129 strains indicates that the 
129S6/SvEvTac and 129S1/SvImJ strains are highly related (Threadgill et al., 
1997), Both were derived from a common ancestor bearing the Steel allele of the 





Laboratories and 129S6/SvEvTac is maintained by Taconic. Since 6 of the 
commonly used mouse embryonic stem (ES) cell lines have been derived from 
these two 129 strains, it is important to document the variants between these two 





CHAPTER 3. ENU MUTAGENESIS REVEALS THAT NOTCHLESS HOMOLOG 
1 (DROSOPHILA) AFFECTS CDKN1A AND SEVERAL MEMBERS OF THE 




The contents in this chapter have been published in BMC Genetics 2012, 13:106. 
 
3.1 Introduction 
Mouse chromosome (Mmu Chr) 11 shares significant synteny conservation with 
regions of six different human (Hsa) chromosomes: 22, 7, 2, 5, 1 and 17 (Boles 
et al., 2009). The largest domain of synteny conservation between mouse and 
human occurs on distal Mmu 11, which is entirely syntenic with Hsa chr 17 
(Hentges et al., 2007). The gene-rich domain flanked by Trp53 and Wnt3 in this 
region of synteny conservation contains 2545 gene structures, including 1597 
predicted protein-coding genes, 450 processed RNAs and 498 pseudogenes 
(Boles et al., 2009).  
 
A large-scale, phenotype-driven ENU (N-ethyl-N-nitrosourea) mutagenesis 
screen targeted to this 34 Mb region of Mmu 11 demonstrated the wide functional 
diversity of this linkage group (Hentges et al., 2006b; Hentges et al., 2007; Kile et 
al., 2003). Functional analysis of 785 total pedigrees from this ENU mutagenesis 
screen resulted in the discovery of a variety of mutant phenotypes, including 
infertility, craniofacial abnormalities, neurological defects and lethality (Kile et al., 
2003). Subsequent studies detailed the embryonic lethal phenotypes of 45 
mutant lines that fell into 40 complementation groups (Hentges et al., 2006b; Kile 
et al., 2003). Resequencing efforts led to the identification of causative or 




Although many mutations were identified in the sequencing study, the lesions in 
the l11Jus1 and l11Jus4 complementation group have yet to be identified. These 
two alleles survive through implantation but arrest prior to embryonic day (E) 6.5 
(Hentges et al., 2006b; Kile et al., 2003). Our interests lie in determining the 
genes and genetic pathways that are important for establishing and maintaining 
maternal-fetal interactions during pregnancy. Since these two mutants fail during 
this critical window, we undertook a positional cloning strategy to identify the 
causative mutations in this complementation group. Here, we present evidence 
that both mutant alleles have non-conservative missense mutations in the 
Notchless homolog 1 (Drosophila) gene, Nle1. Moreover, targeted disruption of 
Nle1 in mice (Cormier et al., 2006b) results in an embryonic lethal phenotype that 
is remarkably similar to l11Jus1 and l11Jus4, providing further supporting 
evidence that Nle1 is disrupted in both mutant alleles. 
NLE1, which is a member of the WD40 repeat protein family, was first identified 
as a suppressor of the notchoid phenotype in Drosophila (Royet et al., 1998a), 
and has been implicated in both positive and negative regulation of NOTCH 
signaling, depending upon developmental stage and species (Cormier et al., 
2006b; Royet et al., 1998a). Studies in Drosophila and Xenopus demonstrate 
that NLE1 signals via the canonical NOTCH pathway (Cormier et al., 2006b; 
Royet et al., 1998a). In invertebrates and lower vertebrates, the NOTCH pathway 
is critical for directing cell fate prior to gastrulation, and also plays important, but 
varied roles in germ layer boundary formation. At the 4-cell stage in C. elegans, 
NOTCH signaling dictates an ectodermal cell fate in ABp daughter cells by 
repressing expression of TBX-37 and TBX-38 (Good et al., 2004). In sea urchins, 
the NOTCH pathway impacts the development and differentiation of the 
secondary mesenchymal cells, which are fated to produce mesodermal cells 
(Sherwood and McClay, 1999, 2001). In contrast, in X. laevis, induction of 
NOTCH signaling leads to an increase in endoderm-specific and a decrease in 
mesoderm-specific markers, while suppression of NOTCH signaling has the 




The role of NOTCH signaling during the earliest stages of mammalian 
development is much less clear. Several lines of evidence demonstrate that 
NOTCH signaling is dispensable for gastrulation in mice. Single gene and 
compound knockout studies of the Notch receptors and ligands results in either 
viable animals or embryonic lethality at mid-gestation (Conlon et al., 1995; 
Dunwoodie et al., 2002; Hamada et al., 1999; Hrabe de Angelis et al., 1997; 
Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000; 
Krebs et al., 2003; McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion 
of genes that block NOTCH signaling, such as Pofut1 and members of the γ-
secretase complex, leads to embryonic failure after gastrulation and midline 
formation. POFUT1 adds O-fucose molecules to NOTCH receptors prior to their 
translocation to the cell surface, while Presenilin 1 and 2 are members of the γ-
secretase complex (Kopan and Ilagan, 2009; Schwanbeck et al., 2011). This 
complex cleaves NOTCH at the cell membrane, releasing the NOTCH 
intracellular domain (NICD) into the cytoplasm. The NICD translocates to the 
nucleus and binds to RBPJ, thereby modulating transcription of downstream 
target genes.  
 
Deletion of Pofut1, which effectively blocks NOTCH signaling through inhibition of  
post-translational modifications to NOTCH receptors (Shi and Stanley, 2006), 
leads to embryonic lethality at E9.5 (Shi et al., 2005a; Shi and Stanley, 2003). 
Targeted disruption of Presenilin 2 in a Presenilin 1 null background leads to 
embryonic lethality at E9.5. Compound mutants exhibit cardiac, somite and 
neurological phenotypes (Donoviel et al., 1999). Finally, deletion of the co-
repressor, Rbpj, causes somitogenesis defects, placental abnormalities and 
marked growth delay (Oka et al., 1995; Souilhol et al., 2006). These studies 
demonstrate that unlike lower vertebrates and invertebrates, and despite the fact 
that Notch receptors and ligands are expressed prior to and during gastrulation 





Since Nle1l11Jus1 and Nle1l11Jus4 mutants have more severe phenotypes than 
mutations that disrupt NOTCH signaling in mice, we hypothesized that NLE1 
interacts with NOTCH and other signaling pathways during pre-implantation 
development. To address this hypothesis, we conducted targeted gene 
expression studies in homozygous mutant embryos. Surprisingly, and in contrast 
to studies in Xenopus and Drosophila, our data indicate that canonical NOTCH 
signaling is not disrupted in Nle1 mutant embryos; instead, we discovered that 
Cdkn1a was upregulated, while several members of the Wnt cascade were 
downregulated in homozygous mutant embryos. These results highlight the 
differences in NOTCH signaling between mammals (where canonical NOTCH 
signaling is dispensable for gastrulation) and other species (where NOTCH 
signaling is required for gastrulation) and indicate that NLE1 could play divergent 






3.2.1 Mouse Strains, Meiotic Mapping and Generation of Mutants 
The l11Jus1 and l11Jus4 mutants were induced by ENU mutagenesis on a 
C57BL/6J background (Hentges et al., 2006b; Kile et al., 2003), and maintained 
in trans using a balancer chromosome (In(11Trp53;11Wnt3)8Brd) harboring a 35 
Mb inversion between Trp53 and Wnt3 that expresses the agouti protein under 
the Keratin 14 promoter (Zheng et al., 1999). Thee inversion animals were on a 
129S6/SvEvTac background. Animals carrying one copy of the balancer 
chromosome have light ears and tails due to ectopic agouti expression that 
reduces pigment (Hentges and Justice, 2004; Hentges et al., 2006b; Kile et al., 
2003; Zheng et al., 1999). The l11Jus1 line has been continually maintained in 
our colony. The l11Jus4 line was resuscitated from cryopreserved spermatozoa 
of an l11Jus4/In(11Trp53;11Wnt3)8Brd male with a C3H/HeJ female 
(www.MMRRC.org, MMRRC:000074-UCD). Pups were genotyped at weaning 
and l11Jus4/C3H/HeJ males were backcrossed to In(11Trp53;11Wnt3)8Brd/Rex 
females on a 129S6/SvEvTAC genetic background. We genotyped the progeny 
of both lines at least every 10 generations by microsatellite analysis or direct 
sequencing of the mutations to ensure that we maintained the mutations.  
 
To generate recombinant animals for meiotic mapping it is necessary to remove 
the balancer chromosome. Animals heterozygous for the l11Jus1 mutation 
(l11Jus1/In(11Trp53;11Wnt3)8Brd) were mated to animals carrying one copy of 
the inversion and the dominant curly coat marker, Rex 
(In(11Trp53;11Wnt3)8Brd/Rex). We selected animals with a curly coat (i.e. 
inherited the Rex allele) and dark ears and tail (i.e. inherited the l11Jus1 mutation) 
for meiotic mapping. We intercrossed F1 animals to generate recombinant F2 
animals, which were genotyped at several microsatellite markers (D11Mit4, 219, 
245, 120, 39, 327, and 32) and single nucleotide polymorphisms (SNPs; Slc6a, 
Wsb1, Rad51l3 and Rasl10) along the 35Mb interval. Primers and PCR 




For the Notch PCR array studies, qRT-PCR analysis and Caspase 3 detection, 
we outcrossed heterozygous males to 129S6/SvEvTac females (Taconic, 
Hudson, New York) to eliminate genetic interactions with Wnt3. Heterozygotes, 
which had light ears and tails (Zheng et al., 1999) were mated, generating F2 
blastocysts for analysis. Notch PCR array studies were conducted on N5F2 
embryos (Nle1l11Jus1). qRT-PCR studies were performed on N14F2 and N15F2 
(Nle1l11Jus1) and N4F2 (Nle1l11Jus4) embryos dissected at E3.5. Caspase detection 
assays were carried out on N15F2 (Nle1l11Jus1), as well as N14F2 or N15F2 
(Nle1l11Jus4) embryos. All mouse studies were conducted in facilities approved by 
the American Association for the Accreditation of Laboratory Animals with the 
approval of the Baylor College of Medicine Animal Care and Use Committee or 
the Purdue University Animal Care and Use Committee.  
 
3.2.2 Embryo Analysis 
To determine time of death and perform phenotypic studies, we examined 
embryos after timed matings, with the day of the vaginal plug designated E0.5. 
We genotyped each one as described (Hentges et al., 2006b; Kile et al., 2003). 
DNA was isolated by incubating whole embryos (E6.5 to E9.5) in 1 X PCR buffer 
(Invitrogen, Carlsbad, CA) and 0.08 mg/ml Proteinase K (Invitrogen, Carlsbad, 
CA) at 55ºC for 2-3 hours. Proteinase K was inactivated by either heating to 95ºC 
for 10 min or by phenol:chloroform:Isoamyl alcohol extraction followed by ethanol 
precipitation. Alternatively, embryos were incubated in 25 to 50 µl of 25 mM 
NaOH, 0.2 mM EDTA for 60 min. at 95ºC. Genomic DNA was neutralized by the 
addition of an equal amount of 40 mM Tris-HCl, pH 8.0 and stored at -20ºC. 
D11Mit327 was used to genotype the embryos in a 25 µl PCR reaction under the 
following conditions:  1 X PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 250 
pmoles of each primer and 0.625 U of Taq Polymerase (Invitrogen, Carlsbad, 
CA). After an initial denaturing step at 95°C for 5 min, D11Mit327 was amplified 
with the following cycling parameters:  30 cycles of 94°C for 30 s, 60°C for 30 s 




were size fractionated on 5% Metaphor (Cambrex, Bio Science, Rockland, ME), 
0.5 X TBE gels. 
 
3.2.3 Histology 
Deciduas were dissected at E6.5–E8.5. Implantation sites were fixed for 3 hours 
in Bouin’s fixative, embedded in paraffin, sectioned in 5–7 µm slices and stained 
in hematoxylin and eosin as described (Noveroske et al., 2002). Stained sections 
were analyzed under light microscopy.  
 
3.2.4 Candidate Gene interrogation 
Exons of candidate genes were bidirectionally sequenced directly from PCR 
amplicons using the Big Dye® Teminator v3.1 (Applied Biosystems, Foster City, 
CA) sequencing mix. Each amplicon contained at least one exon, plus ≥ 200 bp 
of flanking sequence. For the l11Jus1 mutation, genomic DNAs from 
129S6/SvEvTAC, C57BL/6J and l11Jus1/In(11Trp53;11Wnt3)8Brd mice were 
sequenced as controls. For the l11Jus4 mutation, genomic DNAs from 
129S6/SvEvTAC, C57BL/6J, In(11Trp53;11Wnt3)8Brd/C3H, and l11Jus4/C3H, 
and l11Jus4/In(11Trp53;11Wnt3)8Brd mice were sequenced as controls. 
Sequence data was analyzed (Sequencher; Gene Codes, Ann Arbor, MI) to 
identify mutations on the l11Jus1 and l11Jus4 alleles, as well as any additional 
sequence variants. 
 
3.2.5 Notch Pathway Expression of l11Jus1 mutants at E3.5 
We analyzed Notch pathway gene expression in homozygous mutant and 
homozygous wild-type blastocysts using the SAB PCR Arrays 
(SABiosciences/Qiagen, Frederick, MD). Embryos were washed in EmbryoMax© 
M2 media (M2; EMD Milllipore, Billerica, MA) and transferred into 100 µl of 
RNAqueous lysis buffer (RNAqueous-Micro Kit, Applied Biosystems/Ambion, 
Austin, TX). After vortexing, we snap-froze each tube in liquid nitrogen and 




instructions, eluting with 20 µl of nuclease-free water. We used 5 µl of RNA to 
generate cDNA for genotyping in a half reaction of SuperScript One-Step RT-
PCR with Platinum Taq (Invitrogen, Carlsbad, CA) with gene specific primers, 
oligo dT, and PCR primers (Table 3.1). We used nested PCR for sequencing 
(Figure 1E). We collected 45 mutant and 45 wild-type E3.5 embryos, and split 
embryos with the same genotype into 3 pools (i.e. biological replicates); each 
pool consisted of morulae, half-blastocysts, full blastocysts and hatched 
blastocysts. We then performed a linear amplification step on each pool using the 
RT2 Nano PreAMP cDNA synthesis kit (SABioscience, Frederick, MD). Each 
biological replicate was subdivided into 3 technical replicates. Data from each 
PCR plate were analyzed using an iCycler Real Time PCR detection system 









Figure 3.1 Postional cloning of  l11Jus1 and l11Jus4 
A. Exclusion Mapping Breeding Scheme. Blue line: ENU-mutated allele (l11Jus1; 
C57BL/6J); Green line with the double arrow: 35 Mb inversion 
(In(11Trp53;11Wnt3)8Brd;  129S6/SvEvTac); yellow line: dominant Rex allele 
(129S6/SvEvTac), which confers a curly coat. Plus sign: wild type locus. All 
animals carrying two copies of the l11Jus1 allele will die in utero. Representative 
phenotypes and crossover events are depicted in the F2 generation. B. Mapping 
the Nle1 mutation by haplotype analysis in the F2 generation. Each box 
represents a locus within Mmu Chr 11 with color indicating the genotype of the 
animals produced through heterozygous matings. Yellow boxes are non-
informative, homozygous 129S6/SvEvTac genotypes; green boxes are 
heterozygous for 129S6/SvEvTac and C57BL/6J genotypes; while blue boxes 
indicate informative, homozygous C57BL/6J genotypes. Wsb1 & D11Mit120 
define the boundaries of the critical region. C. Physical map of the non-
recombinant interval. Nle1 lies ~700 kb centromeric to D11Mit120. D. Mutation 
analysis. Arrows indicate the location of each mutation. Stacked chromatographs 
show the sequence for each strain. E. The Nle1 cDNA and genotyping primers. 
The full-length, spliced mRNA product is shown with exons represented by empty 
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represented by a thin line on the mRNA transcript. F. NLE1 protein structure. 
Green oval :NLE specific domain; yellow boxes: WD40 Repeat-like domains; 
green diamonds: mutation sites.  
 
 
Table 3.1 Primers used for this study 
      





Nle1 sequencing primers 
E1/2 CTTGACTCCTCCGAACACGAG AAACACAGCCTGTCTGTAGGTGAG 62 500 
E3 GATTAAATTTGTCGCATGGTGGTA GTCTGTTACTTGCAACGTGAGTCC 62 475 
E4 TATTTCTCCTCAGGGAATGGAGAG CCACACTCAGTCCAGTATCTGCTT 62 377 
E5/6 CTGTGTTCTCCCTCACCTCTCC ATAGTAGGCCAAGCCGTTGCT 62 557 
E7 ACAGCCTTGCTCTGCTGTTAGAA GGACCAGCTGGACTCTTGGTATAA 62 440 
E8/9 TTCCTGATTCTTGCCTTATGTCAC AACCCTAACTAAGACAACCAAGAACAA 62 544 
E10 TGGAGTTGCATGTAAGCTTGTGT GTCACTAGCCCTAAAGATGCCATT 62 488 
E11/12 CCGGCCCAGGTACCTAGCTT ACCTACAGGTTCTCCCAGAGTCTCC 62 498 
E13 ACTTGATACTTGGCAGTAGGCACA CTCCTGCTATCCAGTGCAAGG 62 570 
     Nle1 genotyping primers 
GSP GCTGTAATGTCCTGACTGT 
 60 637 cDNA  CTGTGTCGTACTCTTCAAGGTCAT CTGTGGAGTCATCTTCTCCATATC 
cDNA 
2nd TCAGACGACTTCACCTTATTCCTG CAGTCAACAGCATATACCTCATCG 62 351 
gDNA 
geno TCTCCTTCAGCTCCTTCACTGT TCCAATGGTGGAGTATAGGGTATAA 60 341 














cDNA GTGTGACATTTGGTACATGAGGTT ACATTTATGATGGGTCAGTGTTGT 60 148 
     ABI TaqMan gene expression assay 
 
Assay ID Amplicon Size (bp) 
  Trp53 Mm01731290_g1 119 
  Cdkn1a Mm04205640_g1 80 









3.2.6 PCR Array Data Analysis for Gene Expression 
Cycle threshold (Ct) values were calculated for all data obtained from 18 PCR 
plates. We calculated the optimal threshold values based on the value for each 
plate by selecting the auto calculate threshold position and the PCR base-line 
subtracted analysis mode from the iCycler Data Analysis Software (Bio-Rad, 
Hercules, CA). The highest threshold position was 1415 PCR base-line 
subtracted relative fluorescence units (RFU). We re-analyzed each plate by 
entering 1415 as the user defined threshold position. Therefore, we were able to 
compare replicates across multiple plates using Ct values generated from the 
common threshold position. 
 
We used the SABiosciences RT2 Profiler Data Analysis Software to determine 
gene expression profiles (http://www.sabiosciences.com/pcr/arrayanalysis.php). 
This software calculated fold regulation values for each gene using the relative 
quantification 2-∆∆Ct method (Livak and Schmittgen, 2001). Each plate met the 
quality assurance criteria listed by the manufacturer for genomic DNA 
contamination, reverse transcription inhibition, and PCR cycling conditions. ∆Ct 
values were normalized using the mean values of three housekeeping genes: 
Gusb, Hsp90ab1, and Actb. All wells with a Ct value above 29.5 cycles were 
excluded from the analysis. This left 65 transcripts for analysis.  
 
3.2.7 Caspase 3 Detection  
Active Caspases were detected based on a fluorescent inhibitor of Caspases 
(FLICA) approach (Bedner et al., 2000; Slee et al., 1999). Zona-free embryos 
were placed on slides and incubated with FLICA caspase3 reagent (Image-iT™ 
LIVE Red Caspase-3 and -7 Detection Kit, Invitrogen, Grand Island, NY) in M2 
medium at 37°C for one hour. FLICA was removed and the embryos were 
washed with M2 media, counterstained with Hoechst dye for 3 minutes and 
washed with buffer provided by the manufacturer. Embryos were fixed in 1% PFA 




LSM510 microscope (20X objective) and the images were pseudo-colored using 
Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). To genotype, we 
collected each embryo in 10 µl of 100 µg/ml proteinase K solution, incubated the 
embryos at 55°C for 10 minutes, and then heat inactivated at 95°C for 5 minutes. 
We used these lysates to genotype each embryo by two rounds of PCR using 
primers that flanked an insertion/deletion in exon 8. 
 
3.2.8 Quantitative RT-PCR by Taqman 
RNA isolated from embryos separated by genotype (mutant vs. wild-type) and 
stage (morula, full blastocyst and hatched blastocyst) was reverse transcribed 
individually following the protocol by Tang and Colleagues (Tang et al., 2010). 
Following a 1:1 addition of 100% ethanol, RNA was concentrated with a 
SpeedVac for 15 mins, resuspended in 4.5 µl lysis buffer and reverse transcribed. 
We performed a two-step linear amplification process using barcoded primers as 
described (Tang et al., 2010). Products from the first and second rounds were 
purified using Zymo DNA concentration kits (Zymo Research, Irvine, CA) and 
eluted in 30 µl of 1 X T10E0.1. Eed expression was used to check the cDNA 
quality following the first linear amplification step (primers listed in Table 1). 
cDNA was quantified using a Bio-Rad SmartSpec™ Plus Spectrophotometer. 
Ten ng of cDNA was used as a template for qRT-PCR in combination with 
TaqMan® Gene Expression Master Mix (PN#4369514; ABI, Carlsbad, CA) and 
Taqman Gene-specific probes (ABI, Carlsbad, CA) on a Prism 7000HT 
Sequence Detection System (ABI, Carlsbad, CA). We assayed a minimum of 
three biological replicates for each group. Cycling reactions were performed in 
duplicate or triplicate. The relative expression of each gene was calculated based 
on the ΔΔCt value, where the results were normalized to the average Ct value of 
Gapdh. Samples that failed to generate a signal above threshold at the end of 





3.2.9 Statistical Methods 
SAB PCR Array Study. These data can be thought of as a complex nested block 
design: Plate is nested within Pool and Pool is nested within Genotype (Plate and 
Pool are both blocks). Transcript is nested within biological Role (each transcript 
was assigned one biological Role), and transcript and role are crossed with each 
level of nesting (i.e. each transcript is measured on each plate). The data were 
analyzed in a GLM, blocked by Plate nested within Pool, and Pool nested within 
Genotype. Transcript was nested within Role; and Role and Transcript crossed 
with the blocking factors Plate and Pool, and with the experimental factor 
Genotype. Each Plate and Pool acted as its own control. The relationship of 
Plates as technical replicates from the same Pools is recognized. Transcript 
describes the overall expression profile, while Role describes the overall 
Functional Profile, and their interactions with Genotype test (respectively) 
whether particular Transcripts differ from the average for the Role between 
Genotypes, and whether particular Roles differ as a whole between Genotypes. 
We partitioned out between-plate error and used this as the error term for 
analyses for two reasons: 1) the plate reader software controls within plate error 
and 2) the use of between-plate error is conceptually equivalent to (the source of 
error in a traditional ANOVA approach testing each gene independently. By using 
∆Ct values, the analysis directly calculates ∆∆Ct. 
 
qRT-PCR study by TaqMan analysis. We adopted a similar GLM approach to 
individually test and calculate the ∆∆Ct values from Cdkn1a and Trp53 gene 
expression studies. Since we used the –∆Ct for each individual as raw data, 
genotype interactions figures and tests a ∆∆Ct value. We also tested for common 
changes in gene expression in different stages of pre-implantation development 
and used the full pairwise comparisons table to generate the individual ∆∆Ct 







3.3.1 Phenotypic Analysis of l11Jus1 and l11Jus4 
We screened a cohort of 59 lethal mutants (45 of which were embryonic lethal) 
that were generated by ENU mutagenesis (Hentges et al., 2006b), and identified 
an allelic series of two mutants (l11Jus1 and l11Jus4) mapping to mouse 
chromosome 11 that failed to gastrulate. Histological sections performed at 
embryonic day (E) 7.5 show completely resorbing implantation sites compared to 
control littermates (Figure 3.2). In contrast, animals inheriting two copies of the 
35 Mb inversion, In(11Trp53;11Wnt3)8Brd, are homozygous mutant for Wnt3 and 
display a distinct, much less severe phenotype during the gastrulation stage 
(Table 3) (Hentges et al., 2006b; Kile et al., 2003). Complementation studies 
revealed that the phenotype of the l11Jus1/l11Jus4 double heterozygotes is 
identical to either single homozygous mutant (data not shown), thereby placing 
l11Jus1 and l11Jus4 in the same complementation group.  
 
 
Figure 3.2 Mutant phenotypes 
H&E stained sections at E7.5 A. Wild type implantation site B. l11Jus1 
implantation site. C. l11Jus4 implantation site. embryo (Em), extra-embryonic 










Penetrance of l11Jus1 (L1) (Table 3.2A): We genotyped a total of 34 l11Jus1 
(L1/L1) homozygotes (32 normal and 2 abnormal blastocysts), 117 
heterozygotes (L1/Inv) and 49 animals homozygous for the inversion (Inv/Inv). 
We failed to genotype 98 embryos due to lack of DNA from normal (n=40) and 
abnormal (n=2) embryos; resorption sites (n=38) and lost embryos (n=18) 
accounted for the remainder of non-genotyped embryos. At E6.5, we detected 0 
homozygous mutant embryos out of 62 total embryos. X2 analysis indicates that 
these numbers are statistically significant, with p<0.0001 (Table 3). At the 
blastocyst stage (E3.5), we detected normal Mendelian ratios, indicating that the 
time of death occurs between E3.5 and E6.5.  
 
Penetrance of l11Jus4 (L4) (Table 3.2B). We genotyped a total of 28 l11Jus4 
(L4/L4) homozygotes (all normal), 153 heterozygotes (L4/Inv) and 49 animals 
homozygous for the inversion (Inv/Inv). We failed to genotype 58 embryos due to 
lack of DNA from normal (n=9) and abnormal (n=2) embryos; resorption sites 
(n=46) and lost embryos (n=1) accounted for the remainder of non-genotyped 
embryos. At E6.5, we detected 0 homozygous mutant embryos out of 32 total 
embryos. X2 analysis indicates that these numbers are statistically significant, 
with a p-value of 0.004 (Table 3.2). At the blastocyst stage (E3.5), we detected 
all genotypes, but saw an unexpectedly high number of heterozygotes (p=0.014). 
Together, these data indicate that l11Jus1 homozygotes and l11Jus4 












Table 3.2 Time of death for Nle1 mutants 
A. Time of Death for l11Jus1 Mutants 
  Abnormal   Normal     
Day Resorb 
No 
DNA L1/L1 L1/Inv 
Inv/
Inv   
No 
DNA L1/L1 L1/Inv 
Inv/
Inv Lost Total 
3.5 0 2 2 4 3 
 
40 32 58 23 1 165 
6.5 28 0 0 0 18 
 
0 0 42 0 10 98 
7.5 3 0 0 0 1 
 
0 0 5 0 3 12 
8.5 3 0 0 2 3 
 
0 0 1 0 4 13 
9.5 4 0 0 1 1 
 
0 0 4 0 0 10 
Total 38 2 2 7 26   40 32 110 23 18 298 
             B. Time of Death for l11Jus4 Mutants 
  Abnormal   Normal     
Day Resorb 
No 
DNA L4/L4 L4/Inv 
Inv/
Inv   
No 
DNA L4/L4 L4/Inv 
Inv/
Inv Lost Total 
3.5 0 2 0 8 3 
 
6 28 86 27 1 161 
6.5 16 0 0 4 9 
 
0 0 19 0 0 48 
7.5 7 0 0 0 4 
 
0 0 19 0 0 30 
8.5 13 0 0 5 5 
 
0 0 11 0 0 34 
9.5 10 0 0 0 1 
 
3 0 1 0 0 15 











Table 3.3 X2 analysis of selected timed matings 
Genotype Observed Expected Stage Total Embryos p value 
L1/L1 34 50 
All 200 0.018 L1/Inv 117 100 
Inv/Inv 49 50 
      L1/L1 34 30.5 
E3.5 122 0.582 L1/Inv 62 61 
Inv/Inv 26 30.5 
      L1/L1 0 15 
E6.5 60 3.71703E-05 L1/Inv 42 30 
Inv/Inv 18 15 
      
      L4/L4 28 57.5 
All 230 5.17678E-07 L4/Inv 153 115 
Inv/Inv 49 57.5 
      L4/L4 28 38 
E3.5 152 0.014 L4/Inv 94 76 
Inv/Inv 30 38 






  L4/Inv 23 16 
Inv/Inv 9 8 
 
3.3.2 Positional Cloning of l11Jus1 and l11Jus4 
Since L1 and L4 homozygotes failed at the implantation stage, meiotic mapping 
would be difficult, at best, using traditional methods that rely on haplotype 
analysis in phenotypically mutant animals. To circumvent this obstacle, we 
narrowed the critical interval by exclusion mapping (Figure 3.1A). Exclusion 
mapping involves haplotype analysis of all progeny at weaning for several 
markers across the candidate interval (i.e. from Trp53 to Wnt3 on Mmu 11). 
Since homozygous mutants are embryonic lethal, any marker that is 




marker from the candidate interval. Parents were heterozygous for the l11Jus1 
mutation and for the dominant coat color marker, Rex. Throughout the 35 Mb 
critical interval, l11Jus1 is on a C57BL/6J background, while Rex is on a 
129S6/SvEvTac background. Since the balancer chromosome is not present in 
the F1 generation, it is possible to obtain animals that have recombination events 
on one or both parental alleles. These recombination events were visualized by 
haplotype analysis in the F2 generation (Figures 1, 4). We genotyped 487 
progeny (974 individual meiotic events), and narrowed the critical region to a 4.4 
Mb domain flanked by Wsb1 and D11Mit120 (Figure 3.1B, C).  
 
Of the 75 genes in this interval, 16 top candidates were selected based on 
microarray expression data and mutant phenotype. We sequenced 8 of these 
genes in the process of identifying the l11Jus1 and l11Jus4 mutations: adaptor-
related protein complex 2, beta1 subunit (Ap2b1); chaperonin containing Tcp1, 
subunit 6b (zeta) (Cct6b); suppressor of zest 12 homolog (Suz12); fringe isoform 
1 (Rffl); ecotropic viral integration site 2a (Evi2a); proteasome (prosome, 
macropain) 26S subunit non-ATPase 11 (Psmd11); TAF15 RNA polymerase II, 
TATA box binding protein (TBP)-associated factor (Taf15); and Notchless 
homolog 1 (Drosophila) (Nle1).  
 
We found no non-synonymous mutations in our first 7 candidates (Ap2b1, Cct6b, 
Suz12, Rffl, Evi2a, Psmd11 or Taf15) (Lo et al., 2011). However, we identified a 
T 1184 G transversion (I 395 S missense mutation) in l11Jus1 heterozygotes in 
exon 10 of Nle1 (Figure 3.1D). This non-conservative substitution replaces an 
aliphatic, hydrophobic amino acid with a polar residue, which likely disrupts 
functionality (Livingstone and Barton, 1993). Subsequent mutation detection 
efforts resulted in the identification of a second missense mutation (T 484 C 
transition; S 162 P missense mutation) in exon 5 of Nle1 for the l11Jus4 allele 
(Figure 3.1D). This non-conservative amino acid substitution has a high 




polar substrates, while prolines are rarely found in active sites (Livingstone and 
Barton, 1993). In addition, we detected an endogenous C57BL/6J non-
synonymous SNP (A 535 G transition; I 179 V) in exon 6 (Figure 3.1D). This well-
documented SNP (rs2820949) leads to a very conservative amino acid 
substitution (Livingstone and Barton, 1993). Both mutants share the endogenous 
mutation (Figures 2D, 7), indicating that l11Jus1 and l11Jus4 homozygotes 
harbor two coding changes in Nle1–an ENU-induced allele and an endogenous 
C57BL/6J missense mutation.  
 
3.3.3 The Nle1 locus 
BLAT analysis of the mouse RefSeq cDNA (Accession # NM_15431) at the 
UCSC genome browser (Kent, 2002), reveals that the Nle1 locus contains 13 
exons and spans 7628 bp of genomic DNA. cDNA and EST sequences indicate 
the potential for generating several alternatively-spliced transcripts. The RefSeq 
cDNA is predicted to encode a 485 amino acid protein that has an NLE1 domain 
at the N-terminus and 8 WD40-like repeats (Figure 1F). NLE1 is highly 
conserved, with orthologs in multiple species, even yeast and plants; it is over 91% 
identical among mouse, rat, human and cow (Figure 3.3). In addition, it is highly 





Figure 3.3 NLE1 protein sequence alignment 
NLE1 is highly conserved among mouse, rat, cow and human.  
L1              --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58 
L4              --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58 
C57BL/6         --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58 
Mouse           --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58 
CZECHII         --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58 
Rat             MAAAVEVSDEAAASDVQRLLVQFQDEGGQLLGSPFDVPVDITPDQLQLVCNALLAQDEPL 60 
Human           --MAAAVPDEAVARDVQRLLVQFQDEGGQLLGSPFDVPVDITPDRLQLVCNALLAQEDPL 58 
Cow             -MAAAAAADEAATRDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEDPL 59 
                   *. . :**.: ******************************:***********::** 
 
L1              PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118 
L4              PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118 
C57BL/6         PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118 
Mouse           PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118 
CZECHII         PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118 
Rat             PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 120 
Human           PLAFFVHDAEIVSSLGKTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI 118 
Cow             PLAFYVHDAEIVSSLGRTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI 119 
                ****:***********:*****:*****::********:********************* 
 
L1              SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178 
L4              SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSIPWSPDGKKLASGCKNG 178 
C57BL/6         SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178 
Mouse           SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178 
CZECHII         SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178 
Rat             SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 180 
Human           SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGRKLASGCKNG 178 
Cow             SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCQGHRHWVLSISWSPDGKKLASGCKNG 179 
                **********************************:*********.*****:********* 
 
L1              QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238 
L4              QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238 
C57BL/6         QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238 
Mouse           QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238 
CZECHII         QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238 
Rat             QILLWDPSTGTQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 240 
Human           QILLWDPSTGKQVGRTLAGHSKWITGLSWEPLHANPECRYVASSSKDGSVRIWDTTAGRC 238 
Cow             QILLWDPSTGKQVGRALTGHSKWITALSWEPLHANPECRYVASSSKDGSVRVWDTTAGRC 239 
                *:******** ****:*:*******.******* *****************:******** 
 
L1              ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
L4              ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
C57BL/6         ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
Mouse           ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
CZECHII         ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
Rat             ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 300 
Human           ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298 
Cow             ERTLTGHAQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 299 
                ** ****:**************************************************** 
 
L1              YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
L4              YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
C57BL/6         YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
Mouse           YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
CZECHII         YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
Rat             YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 360 
Human           YALRTGAFEPAEASVNPQDLQGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP 358 
Cow             YALRTGAFEPAEASVNAQDLRGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP 359 
                *************:**.***:***:****** **************************** 
 
L1              AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSVKLWDGRTGKYLASLRGHVAAVY 418 
L4              AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418 
C57BL/6         AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418 
Mouse           AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418 
CZECHII         AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418 
Rat             AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 420 
Human           AEDKKPLTRMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418 
Cow             AEDKKPLARMTGHQALINQVVFSPDSRVIASASFDKSIKLWDGRTGKYLASLRGHVAAVY 419 
                *******:************:******::********:********************** 
 
L1              QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
L4              QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
C57BL/6         QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
Mouse           QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
CZECHII         QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
Rat             QIAWSADSRLLVSGSSDSTLKVWDVKAQKLTTDLPGHADEVYAVDWSPDGQRVASGGKDK 480 
Human           QIAWSADSRLLVSGSSDSTLKVWDVKAQKLAMDLPGHADEVYAVDWSPDGQRVASGGKDK 478 
Cow             QIAWSADSRLLVSGSSDSTLKVWDVKAQKLSTDLPGHADEVYAVDWSPDGQRVASGGKDK 479 
                ******************************: **************************** 
 
L1              CLRIWRR 485 
L4              CLRIWRR 485 
C57BL/6         CLRIWRR 485 
Mouse           CLRIWRR 485 
CZECHII         CLRIWRR 485 
Rat             CLRIWRR 487 
Human           CLRIWRR 485 
Cow             CLRIWRR 486 




3.3.4 Expression Analysis of the Notch Pathway in Mutant Embryos 
Since Nle1l11Jus1/l11Jus1 embryos die shortly after implantation, while disruption of 
NOTCH signaling by multiple methods (i.e. targeted deletion of Notch receptors 
and ligands, (Conlon et al., 1995; Dunwoodie et al., 2002; Hamada et al., 1999; 
Hrabe de Angelis et al., 1997; Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al., 
2004; Krebs et al., 2000; Krebs et al., 2003; McCright et al., 2001; Swiatek et al., 
1994), γ-secretase (Donoviel et al., 1999) or Pofut1 (Shi et al., 2005a; Shi and 
Stanley, 2003)) in mice leads to embryonic lethality after mid-gestation, we 
hypothesized that Nle1l11Jus1/l11Jus1 and Nle1l11Ju41/l11Jus4 mutants had defects in 
multiple signaling pathways. To test for defects in NOTCH signaling, we analyzed 
Notch pathway gene expression in homozygous mutant (i.e. Nle1l11Jus1/l11Jus1) 
blastocysts using the PAMM-059 Notch Pathway SAB PCR Array 
(SABiosciences/Qiagen, Frederick, MD). We compared expression levels of 84 
Notch pathway genes in Nle1l11Jus1/l11Jus1 pre-implantation embryos to Nle+/+ 
control littermates.  
 
We eliminated 19 genes, including 8 Notch downstream targets (Cflar, Ifng, Il2ra, 
Pparγ, Cd44, Dtx1, Krt1 and Ptcra) and the Notch ligand, Dll1, due to lack of 
expression (i.e. had a Ct value ≥ 29.5). This left 65 genes for statistical analysis, 
including the Notch receptors (Notch1-4), Jagged ligands (Jag1-2) and receptor 
processing and modifying enzymes (i.e. the γ-secretase complex and protein O-
fucosyltransferase genes: Adam10, Adam17, Psen1, Psen2, Psenen and Pofut1).  
Notch target genes include Cdkn1a (a marker of cell cycle arrest), Hes1, Hey1, 
Stat6, Nr4ar, Nfkb1 and Pparg (transcriptional regulators), Ccnd1 (cell cycle), as 
well as Chuk, Il17b and Krt1 (downstream targets with unspecified functions in 
the NOTCH pathway). In addition, the PCR array contains several members of 
the Wnt (Aes, Axin1, Lrp5, Fzd1-7 and Wnt11) and Hedgehog signaling 
pathways (Gli1, Gsk3, Shh, Smo and Sufu). To ensure biological significance, 
genes with less than a 1.5 fold change were included in the statistical analyses, 




We analyzed the data using a GLM blocked by plate (technical replicate) nested 
within pool (biological replicate) and pool nested within genotype. Transcript 
levels were nested within biological function/pathway (role). Role and transcript 
were crossed with the blocking factors plate and pool, and with the experimental 
factor genotype. Therefore, testing for genotype X transcript interactions will 
identify single genes that are statistically upregulated or downregulated in mutant 
embryos, while testing for genotype X role interactions identifies groups of genes 
with similar biological functions (i.e. Wnt pathway, transcriptional regulation, etc.) 
that are as a whole misregulated in mutant embryos compared to wild-type 
controls. The Role (GLM: F7,84=248.3; P<0.0001) and Transcript (F7,84=224.0; 
P<0.0001) effects were significant, indicating the presence of consistent 
functional and expression profiles in both genotypes.  
 
The Genotype*Transcript interaction was significant (F57,684=1.5490; P=0.0073), 
indicating that at least one transcript differed from the overall mean of transcripts 
within the same Role. Of the 16 Notch target genes detected in this study, 6 were 
overexpressed by at least 1.5 fold (Cdkn1a, Nfkb1, Hes1, Erb2, Il17b, Mapk27). 
However only Cdkn1a, which was upregulated by 4.7 fold in mutant samples 
(Figure 3.4) (p=1.94X10-8), was statistically significant using post hoc tests 
corrected for multiple comparisons (accepting p<0.000769); none of the other 
genes approached significance, even at an uncorrected threshold of p<0.05.  
 
Seven genes demonstrated a more than 1.5 fold reduction in expression in 
Nle1l11Jus1/l11Jus1 embryos: Lrp5, Fzd7, Fzd4 and Wnt11, which are members of 
the Wnt signaling pathway, and Chuk, Nr4a2 and Stat6. However, none of these 
met the rigorous criteria (p<0.000769) that accounts for the multiple comparison 
analysis. Setting aside Bonferroni corrections for false positive detection rate, 
and accepting a false discovery rate (FDR) of 5% leads to the inclusion of Fzd7 
(p=0.00168), Nr4a2 (p=0.00422), Fzd4 (p=0.00461) and Chuk (p=0.02492); 





























































































































Figure 3.4 Expression of Nle1l11Jus1 embryos using a Notch-specific PCR array 
Each transcript is listed (left), with fold change indicated (top). The mean 
expression level for each transcript is indicated. The least-squares mean ΔΔCT 
±SE is shown for each transcript, with equivalent fold-change. The dashed line 
indicates that Cdkn1a is the only gene with significant differences in expression 
following a Bonferonni correction for multiple comparisons. The dotted line 
represents transcripts where p < 0.05. Biological roles were taken directly from 
the SAB website.  
 
This analysis indicates that multiple members of the Wnt pathway are 
downregulated in Nle1 mutant embryos.  
 
3.3.5 Confirmation of Cdkn1a in Different Stages in Pre-Implantation 
The SAB PCR array study was performed on three pools (n=15) of E3.5 embryos 
at different stages (i.e. a mix of morula, blastocysts and hatched blastocysts). 
This could have introduced biased expression or masked subtle alterations in 
stage-specific gene expression due to pooling of embryos from different stages. 
To control for these possibilities and confirm the PCR array results, we analyzed 
expression of Cdkn1a between wild type and mutant embryos at multiple 
embryonic stages (morula, full blastocyst and hatched blastocyst) in single 
embryos using TaqMan assays. Expression of each gene was normalized 
relative to expression of Gapdh and compared to the stage-matched wild type 
controls. Wild type expression was set at a value of one. 
 
We used a multivariate GLM model to calculate ΔΔCt and fold change and to 
properly control and test for differences between the mutant alleles and stages of 
development. Using a least squares mean, which corrected for all of the 
variables in the analysis (line, genotype, stage of development), we did not 
detect differences in Cdkn1a expression between mutants compared to control 
embryos as a function of stage (morula, blastocyst and hatchet blastocyst; 
F2,32=0.2701; P=0.7650), line (Nle1l11Jus1 and Nle1l11Jus4; F1,32=1.293; P=0.2640) 




differences in expression due to developmental stage or mutant line. However, 
overall, Cdkn1a was expressed at 4.69 fold (95% CI: 1.02 - 21.5 fold) higher 
levels both in Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4 mutant embryos compared to 
wild-type controls at all stages (GLM: F1,32=4.2561; P=0.0473). These data are 
consistent with our PCR array findings for l11Jus1 mutant embryos, show that 
there are no significant differences in expression of Cdkn1a at the different 
stages tested in the PCR array, and demonstrate that the phenotypes associated 
with l11Jus1 and l11Jus4 do not differ at the molecular level.  
 
3.3.6 Apoptosis Occurs at E4.5 in Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4 Mutants  
These Cdkn1a expression findings are intriguing, as targeted disruption of Nle1 
in mice indicated that mutant embryos started to undergo apoptosis at E3.5 plus 
1 day in culture, which is approximately equivalent to E4.5 embryos (i.e. hatched 
blastocysts) (Cormier et al., 2004a). If our mutant embryos were also undergoing 
apoptosis, we would expect that they would not show high levels of Cdkn1a, as 
Cdkn1a expression is most often an indication that cells have exited the cell 
cycle following a DNA damage response or other type of cellular stress event 
(Brugarolas et al., 1995; Deng et al., 1995). However the function of CDKN1A in 
cell cycle arrest and apoptosis is still unclear, as other studies have shown that 
Cdkn1a expression levels can be upregulated in cells undergoing apoptosis 
(Gartel, 2005). Given that Cdkn1a was expressed at much higher levels in Nle1 
mutants compared to wild-type embryos, we hypothesized that animals 
expressing high levels of Cdkn1a would be protected from apoptosis at E3.5, but 
would ultimately become apoptotic by E4.5, which would be consistent with 
previous studies (Cormier et al., 2004a).  
 
Therefore, we analyzed Caspase 3 activity at E3.5 and E4.5 (Figure 3.5; Table 
3.4). We tested these data in a single logistic multiple regression. We detected 
Caspase 3 activity solely in homozygous mutants (Likelihood Ratio χ2 = 21.75; 




χ2 < 0.0001; p>0.9999). We did not find any evidence for an interaction between 
genotype and stage (LR χ2 < 0.0001; p>0.9999).  Overall, these data indicate 
that apoptosis appears at E4.5, but not at E3.5; that apoptosis is only seen in 
homozygous mutants, and that these two effects are independent and additive in 
both alleles.  
 
 
Figure 3.5 Caspase 3 detection in Nle1l11Jus1 mutant embryos 
Caspase 3 detection in mutant and wild type embryos at E3.5 (200X) and E4.5 
(200X). Positive Caspase 3 staining is only detected in E4.5 mutants. Red 
staining indicates the presence of Caspase 3 signal and blue is Hoechst staining. 











Table 3.4 Logistic multiple regression analysis of caspase 3 detection 
Genotype/stage Homozygous WT Heterozygous Homozygous Mutant Total 
Caspase 3 + – + – + –  
l11Jus1 E3.5 
morula/blastocyst 0 1 0 5 0 2 8 
l11Jus1 E4.5                    
hatched blastocyst 0 2 0 5 2 0 9 
l11Jus4 E3.5 
morula/blastocyst 0 4 0 5 0 3 12 
l11Jus4 E4.5          
hatched blastocyst 0 3 0 4 3 0 10 
 
 
3.3.7 qRT-PCR Analysis of Trp53 in Mutant Embryos 
We then asked whether the apoptotic phenotype is Trp53-dependent. Taqman 
assays were conducted to compare Trp53 expression between wild-type and 
mutant embryos. Identical GLM models were used to calculate fold change and 
test significance, with additional planned contrasts performed to test differences 
at different embryonic stages. Trp53 expression did not differ between control 
and mutant embryos overall (GLM: F1,33=0.5316; P=0.4711), by line 
(F1,33=0.0057; P=0.9404), by embryonic stage (F2,33=0.0994; P=0.9056), or the 
interaction of line and stage (F2,33=0.1782; P=0.8376).  
 
Together, the gene expression and Caspase 3 data indicate that Nle1l11Jus1/l11Jus1 
and Nle1l11Jus4/l11Jus4 homozygotes undergo Caspase 3-mediated apoptosis at the 
hatched blastocyst stage. This is not mediated by alterations in mRNA levels of 
Trp53, and apoptosis does not correlate with upregulation of Cdkn1a expression 
in homozygous mutant embryos, as upregulation of Cdnk1a occurs from the 
morula through the hatched blastocyst stage, even though apoptosis only is 
observed at the latest stages. Furthermore, we demonstrate that several 
members of the Wnt pathway are downregulated in mutant embryos, suggesting 






We present evidence that the l11Jus1 and l11Jus4 mutant phenotypes are 
caused by non-conservative missense mutations in the Nle1 gene. Gene 
targeting studies indicate that l11Jus1 and l11Jus4 phenocopy the null allele 
(Cormier et al., 2006b). These ENU mutants were created on a C57BL/6J 
background, which also contains a conservative missense mutation in Nle1. 
Therefore, l11Jus1 and l11Jus4 homozygotes harbor two mutations within 
predicted functional domains of NLE1. Previous studies in Drosophila and 
Xenopus indicate that NLE1 is a member of the NOTCH pathway (Cormier et al., 
2006b; Royet et al., 1998a). NOTCH signaling facilitates short-range cell-cell 
communication during diverse cellular processes, in multiple tissues and at a 
multitude of developmental stages. Loss of function or gain of function mutations 
in various factors that are fundamental to canonical NOTCH signaling are often 
associated with developmental disorders, adult-onset diseases and a variety of 
cancers in humans (Kopan and Ilagan, 2009). 
 
However, the function of NLE1 in NOTCH signaling remains elusive. Initial 
studies in Drosophila show that NLE1 function is context and dosage dependent. 
NLE1 was identified as a dominant suppressor of the viable mutant allele, 
notchoid (Royet et al., 1998a). Notchoid mutants have characteristic wing 
notches; in the notchoid mutant background, Nle1 heterozygosity (i.e. Nle1/+) 
rescued the notchoid phenotype, while simultaneously causing shortened and 
thickened wing veins (Royet et al., 1998a). Interestingly, overexpression of 
wingless, the Drosophila Wnt ortholog, in the notchoid background also rescues 
the notchoid phenotype (Couso and Martinez Arias, 1994; Hing et al., 1994), 
while overexpression of Notch leads to shortened, thickened wing veins 
(Matsuno et al., 1995). Since NLE1 can bind the NOTCH intracellular domain 
(NICD), these experiments suggest that NLE1 is a negative regulator of NOTCH, 
and that NLE1 functions by blocking the ability of the NICD to regulate 




conclusion, as overexpression of Murine (Cormier et al., 2006b) or a combination 
of Xenopus and Drosophila (Royet et al., 1998a) Nle1 mRNAs into single 
blastomeres at the 4-cell or 2-cell stage, respectively, lead to decreased numbers 
of primary neurons at the early neurula stage. These results indicate that NOTCH 
activity was upregulated following injection of Nle1 mRNAs, suggesting that 
NLE1 positively regulates NOTCH signaling.  
 
These studies indicate that NLE1 acts as both a positive and negative regulator 
of NOTCH signaling. If NLE1 acts as a general positive regulator of NOTCH 
signaling during murine pre-implantation development, then elimination of NLE1 
could lead to compensatory over-expression of the Notch receptors, ligands and 
protease family members, but reduced expression of downstream target genes. 
In contrast, if NLE1 functions as a negative regulator of NOTCH signaling, we 
would predict that disruption of NLE1 would lead to increased expression of 
Notch target genes. To our surprise, we saw no generalized misregulation of 
Notch target genes in the PCR array study. In addition, the Notch receptors, 
ligands and other family members were not significantly altered. At a false 
discovery rate of 5%, the only genes that are misregulated in the PCR array 
study were:  Cdkn1a, Nr4a2, Fzd7, Fzd4 and Chuk. Cdkn1a, Nr4a2 and Chuk 
are downstream targets of NOTCH signaling, while Fzd7 and Fzd4 encode 
receptors in the WNT pathway. To tease out the gene expression changes that 
occurred during specific pre-implantation stages, we analyzed expression of 
Cdkn1a on individual staged embryos (morulae, full blastocysts and hatched 
blastocysts). Cdkn1a was significantly upregulated in Nle1l11Jus1/l11Jus1 and 
Nle1l11Jus4/l11Jus4 animals at all three stages. These studies indicate that mutations 
in Nle1 do not significantly affect the NOTCH pathway during pre-implantation 
development.  
 
CDKN1A is a powerful cyclin-dependent kinase inhibitor that functions in several 




TRP53-mediated response to DNA damage (Abbas and Dutta, 2009). This can 
happen directly by competing with DNA polymerase δ  for PCNA binding sites at 
the replication fork, leading to decreased DNA synthesis (Moldovan et al., 2007). 
Alternatively, CDKN1A can inhibit CDK2, which leads to suppression of E2f-
dependent transcripts, downregulation of components of the DNA synthesis 
machinery and reduced firing at origins of replication (Zhu et al., 2005). In 
addition, CDKN1A can act as a negative regulator of Caspase-mediated 
apoptosis (Abbas and Dutta, 2009). Gene targeting studies demonstrated that 
the inner cell mass of Nle1-/- embryos was undergoing apoptosis via a caspase-
dependent mechanism in E3.5 blastocysts that were cultured for 24 hours 
(Cormier et al., 2006b). We analyzed Caspase 3 activity in blastocysts and 
hatched blastocysts at E3.5 and E4.5. Consistent with the results of Cormier and 
colleagues (2006), we demonstrate that l11Jus1 and l11Jus4 show evidence of 
apoptosis only in hatched blastocysts.  
 
Although we show upregulation of Cdkn1a and downregulation of several 
members of the Wnt pathway, how these two networks work together to regulate 
pre-implantation development is still unknown. One attractive possibility is via the 
TRP53-mediated stress response pathway, which is upstream of CDKN1A. We 
predicted that if our Nle1 mutations were causing severe cellular damage, the 
cell would not be able to recover during cell cycle arrest (at E3.5), which would 
then force the cell to undergo apoptosis (at E4.5). If this were true, we would 
expect to see increased expression of Trp53, as the cells proceeded through 
apoptosis. However, we did not detect altered expression of Trp53 by qRT-PCR 
studies in our mutants at any stage. In retrospect, this result is not that surprising, 
as TRP53-mediated apoptosis (via Cdkn1a upregulation) is not necessarily 
correlated with mRNA expression of Trp53, but is instead associated with 
upregulation of the active, acetylated form of the TRP53 protein (Yamakuchi and 




Trp53 were too subtle to detect, or apoptosis could be occurring via non-TRP53 




CHAPTER 4. NLE1 MISSENSE MUTATIONS TIGGER TRP53 ACTIVATION 






Previously, we reported that missense mutations in Notchless (Nle1) result in 
embryonic lethality at peri-implantation (Lossie et al., 2012). Mutant embryos 
implant and elongate, but fail to establish and/or maintain maternal/fetal contacts, 
ultimately failing prior to gastrulation. Nle1 mutant embryos display alter 
expression of Cdkn1a and several members of the Wnt pathway (e.g. Fzd4, Fzd7, 
and Wnt11). The Wnt pathway is critical for establishing and maintaining 
pregnancies (Pey et al., 1998; Wang et al., 2004; Xie et al., 2008). For example, 
targeted disruption of Wnt3 results in embryonic lethality prior to primitive streak 
formation (Barrow et al., 2007). Wnt pathway genes are highly expressed in 
blastocysts (Kemp et al., 2005; Kemp et al., 2007; Lloyd et al., 2003; Mohamed 
et al., 2004), as well as in the uterus during peri-implantation (Hayashi et al., 
2007; Hayashi et al., 2009; Miller and Sassoon, 1998). 
 
CDKN1A is thought to play important roles in cell cycle arrest and/or apoptosis 
through activation of TRP53-mediated programmed cell death (Abbas and Dutta, 
2009). Activation of TRP53 can be induced by cellular stress or DNA damage 
(Yuan et al., 2005). In our case, we believe the cellular stress is resulted from the 
missense mutation in NLE1. Therefore, it is crucial to tease out the functional role 
of NLE1 in mouse early development. Nle1 was first identified as a suppressor of 





the intracellular domain of Notch (Royet et al., 1998). NLE1 acts both as a 
positive and a negative regulator of NOTCH signaling, depending upon 
developmental stage and species (Cormier et al., 2006b; Royet et al., 1998a). 
Studies in Drosophila and Xenopus demonstrate that NLE1 signals via the 
canonical NOTCH pathway (Cormier et al., 2006b; Royet et al., 1998a). In 
invertebrates and lower vertebrates, the NOTCH pathway is critical for directing 
cell fate prior to gastrulation, and also plays important, but varied roles in germ 
layer boundary formation (Good et al., 2004). However, our findings refute the 
possibility of NLE1 in the NOTCH pathway in mouse early development, as 
mutation of Nle1 does not lead to altered expression of Notch downstream genes 
(Lossie et al., 2012). Furthermore, several lines of evidence demonstrate that 
NOTCH signaling is dispensable for gastrulation in mice. Single gene and 
compound knockout studies of the Notch receptors and ligands results in either 
viable animals or embryonic lethality at mid-gestation (Conlon et al., 1995; 
Dunwoodie et al., 2002; Hamada et al., 1999; Hrabe de Angelis et al., 1997; 
Jiang et al., 1998a; Jiang et al., 1998c; Krebs et al., 2004; Krebs et al., 2000; 
Krebs et al., 2003; McCright et al., 2001; Swiatek et al., 1994). Similarly, deletion 
of genes that block NOTCH signaling, such as Pofut1 and members of the g-
secretase complex, leads to embryonic failure after gastrulation and midline 
formation (Shi et al., 2005a; Shi and Stanley, 2003). These studies demonstrate 
that unlike lower vertebrates and invertebrates, and despite the fact that Notch 
receptors and ligands are expressed prior to and during gastrulation (Cormier et 
al., 2004a), NOTCH signaling is dispensable prior to gastrulation in mice.  
 
Several studies in yeast and plants (which lack NOTCH signaling) demonstrate a 
role for NLE1 in ribosomal biogenesis (Chantha et al., 2007a; Chantha et al., 
2006; Chantha and Matton, 2007; de la Cruz et al., 2005b; Strain et al., 2001). 
Ribosomal biogenesis is necessary during preimplantation development, as 
genetic ablation of proteins involved in rRNA processing usually causes growth 




Romanova et al., 2006; Zhang et al., 2008). For instance, in mice with mutations 
in the proteins involved in ribosomal rRNA synthesis and processing, such as 
pescadillo-1 (PES1) (Lerch-Gaggl et al., 2002), RNA polymerase 1 (Rpol1) 
(Yamamura et al., 2008), surfeit gene 6 (SURF6) (Romanova et al., 2006), RNA 
binding motif protein 19 (RBM19) (Zhang et al., 2008), EMG1 nucleolar protein 
homolog (S. cerevisiae) (EMG1) (Ding et al., 2010), WD repeat domain 36 
(WDR36) (Gallenberger et al., 2011), and lin-28 homolog A (C. elegans) LIN28a 
(Vogt et al., 2012), mutant embryos are arrested at the morula stage, leading us 
to hypothesize that NLE1 is involved in murine ribosomal biogenesis pre-
implantation development.  
 
The general paradigm for ribosomal biogenesis is the coordinated assembly of 
approximately 80 ribosomal proteins and four ribosomal RNAs to generate the 
60S and 40S ribosome precursors(Lempiainen and Shore, 2009). This process 
requires all of the RNA polymerases. RNA polymerase I transcribes the 47S 
precursor rRNA, which is subsequently processed into 28S, 18S and 5.8S rRNAs. 
5S rRNA is transcribed by RNA polymerase III, translocated to the cytoplasm and 
then imported back into the nucleolus where it incorporates into the large 
ribosomal subunit (Venema and Tollervey, 1999). Ribosomal proteins and other 
factors that assist rRNA processing and assembly, rRNA export and final 
maturation are transcribed by RNA polymerase II (Kressler et al., 1999). Mis-
regulation of ribosomal biogenesis (e.g. defects in rRNA transcription and 
disruptions in rRNA processing) triggers ribosomal stress, and in most case, 
causes the breakdown of nucleolar structure which leads to activation of the RP-
MDM2-p53 pathway and p53-dependent cell cycle arrest and/or apoptosis 
(Deisenroth and Zhang, 2010) .   
 
Several lines of studies have shown that the appropriate amount of ribosome is 
required for allowing G1-S transition and further regulates cell cycle progression 




ribosomal protein S6 in mouse hypatocytes leads to defects in 40S ribosome 
production and a block of entry into S phase (Volarevic et al., 2000). Drug 
induced inhibition of rRNA synthesis caused a delay in the G1-S transition due to 
the reduction of 18S and 28S rRNA produced during the G1 phase (Derenzini et 
al., 2005).  These pieces of evidence point out that there appears to be a 
threshold level of ribosomes necessary for progression in the cell cycle, and that 
disruptions in rRNA processing could seriously disrupt important cellular 
checkpoints during pre-implantation development.   
 
P53 is part of a feedback loop that includes the E3 ubiquitin ligase MDM2, as 
MDM2 catalyzes ubiquitination of P53, leading to protein degradation (Deisenroth 
and Zhang, 2011). Many of the p53 regulators function through binding to and 
inhibiting the function of MDM2 or induce posttranslational modifications that 
block the MDM2-P53 interaction. Upon induction, the nucleolar protein ARF 
(Alternative Reading Frame), a product of the INK4A/ARF locus, binds to MDM2 
to inhibit degradation of P53 (Sharpless, 2005). In addition, protein modifications 
to MDM2 (e.g. ubiquitination, sumoylation and phosphorylation) inhibit the 
MDM2-p53 interaction, thereby stabilizing p53 activity (Meek and Knippschild, 
2003). Like ARF, a number of ribosomal protein (RPs) have been reported to 
interact with MDM2 to block p53 ubiquitination, and specifically ‘lock in’ the active 
form of p53 (Deisenroth and Zhang, 2011). For instance, the ribosomal proteins 
RPL5, PRL11, RPL23 and S7 bind MDM2 and therefore stabilize p53 activity. 
Furthermore, inhibition of rRNA transcription by drugs (5-fluorouracil, actinomycin) 
or by deleting the Pol I complex also causes similar outcomes through RP-
dependent inactivation of MDM2. The active p53 thereby induces the expression 
of Cdkn1a, inhibits cyclin E/Cdk2 complexes and leads to pRB-dependent cell 
cycle arrest (Zhao et al., 2003).  
 
In yeast, NLE1 (Rsa4) mutations block processing of the 35S/27S precursor 




corresponding mammalian transcripts are the 36S/32S pre-rRNA, and the mature 
28S and 5.8S rRNAs). Given that mutations in Nle1 induce Cdkn1a and 
ultimately lead to apoptosis (Lossie et al., 2012), we hypothesize that the primary 
cellular insult to the mutant embryos was a disruption in rRNA processing of the 
36S/32S pre-rRNA transcript that activates the RP-MDM2-p53 pathway and 
leads to cell cycle arrest and/or apoptosis in mutant embryos. To test this 
hypothesis, we determined that TRP53 is activated in the mutants and several 
TRP53 regulated genes involved cell cycle and apoptosis pathways are mis-
expressed. Next, we performed RNASeq using the MiSeq platform to sequence 
and quantify total cellular rRNA. We also examined nucleologenesis by detecting 


























Incubation of the embryos in acid Tyrode’s solution (Sigma-Aldrich, Cat# T1788-
100ML, St. Louis, MO) denuded the embryos of the zona pellucida. Embryos 
were fixed in 1% paraformaldehyde for 10 minutes, wash in 1X PBS, and then 
directly stored in 70% Ethanol at 4°C for later use. Fixed embryos were washed 
three times in PBST (0.1% Triton X-100 in 1X PBS), permeabilized for 30 
minutes in 0.5% Triton in PBS at room temperature, and blocked for two hours in 
3% BSA, 0.1% Triton X-100 in PBS at room temperature. Embryos were then 
incubated with the primary antibody in blocking buffer at 4°C overnight. The 
primary antibodies used in this study are rabbit polyclonal anti-Fibrillarin antibody 
(1:100 dilution) (Abcam, Cat# ab5821, Cambridge, MA) and rabbit polyclonal 
anti-p53 (acetyl K378) (1:750 dilution) (Abcam, Cat# ab61241, Cambridge, MA). 
We incubated the embryos in Chromeo 642 Goat Anti-Rabbit secondary antibody 
(Active Motif, Cat# 15044, Carlsbad, CA) using a 1: 1000 dilution in PBST for one 
hour at room temperature. Embryos were washed in 1 X PBST in 0.5 ul 
eppendorf tubes for 3 X 10 minutes between each step and stirred with pipette 
tips. Embryos were counterstained with Hoechst dye for 15 minutes and mounted 
on slides for imaging. Each embryo was imaged using a Zeiss LSM510 
microscope (20 X objective); images were pseudo-colored using Adobe 
Photoshop (Adobe Systems, Inc., San Jose, CA). We genotyped each embryo 
following immunofluorescence analysis by collecting them separately in 10 µl of a 
100 µg/ml proteinase K solution prepared in PCR water. Embryos were lysed by 
incubation at 55°C for 10 minutes, followed by heat inactivated at 95°C for 5 
minutes to the eliminate proteinase K. We used these lysates to genotype each 
embryo by two rounds of PCR using primers that flanked an insertion/deletion in 




Table 4.1 Primers used for this study 
 
 
4.2.2 Quantitative RT-PCR 
Individual total RNA from each embryo was segregated according to genotype 
(mutant vs. wild-type) and stage (morula, full blastocyst and hatched blastocyst). 
cDNA from individual embryos was produced from reverse transcription following 
the protocol by Tang and Colleagues (Tang et al., 2010). RNA was precipitated 
by addition of 100% ethanol (1:1; V:V) in a 15 minute SpeedVac run and 
resuspended in 4.5 µl of lysis buffer prior to reverse transcription using a two-
step linear amplification process with barcoded primers (Tang et al., 2010). 
Products from the first and second rounds were purified using Zymo DNA 
concentration kits (Zymo Research, Irvine, CA) and eluted in 30 µl of 1 X T10E0.1. 
Eed expression was used to check the cDNA quality following the first linear 
amplification step. cDNA was quantified using a Bio-Rad SmartSpec™ Plus 
Spectrophotometer, and 10 ng of cDNA was used as a template for qRT-PCR in 
combination with TaqMan® Gene Expression Master Mix (PN#4369514; ABI, 
Carlsbad, CA) and Taqman Gene-specific probes (Life Technologies, Grand 
Island, NY) (Table 4.1) on a StepOnePlus™ Real-Time PCR System (Life 
Table 4.1. Primers used for this study
Forward Sequence Reverse Sequence Tm
Amplicon 
Size (bp)
Nle1  GSP GCTGTAATGTCCTGACTGT
cDNA geno CTGTGTCGTACTCTTCAAGGTCAT CTGTGGAGTCATCTTCTCCATATC
cDNA geno 2nd TCAGACGACTTCACCTTATTCCTG CAGTCAACAGCATATACCTCATCG 62 351











Eed cDNA GTGTGACATTTGGTACATGAGGTT ACATTTATGATGGGTCAGTGTTGT 60 148
















Technologies, Grand Island, NY). We assayed a minimum of three biological 
replicates for each group; cycling reactions were performed in duplicate. The 
relative expression of each gene was calculated based on the ΔΔCt value, where 
the results were normalized to the average Ct value of Gapdh. Samples that 
failed to generate a signal above threshold at the end of the reaction were given 
a Ct value of 40, as described previously (Lossie et al., 2012) .  
 
4.2.3 Sample Preparation for rRNASeq 
We staged E3.5 embryos and collected four mutants and four wild-type morulae 
for this study. To examine the repertoire of rRNA in these samples, we extracted 
total RNA from single embryos; we genotyped each embryo using 25% of the 
total RNA, as described (Lossie et al., 2012). Total RNA was reverse transcribed 
using the iScript cDNA synthesis kit (Bio-Rad, Cat#170-8890, Hercules, CA) 
according to manufacturer’s instructions. The iScript system contains both 
oligo(d)T and random hexamers, to ensure accurate representation of rRNA 
transcripts. The entire 20ul solution was concentrated using SpeedVac for 10 
minutes to obtain the appropriate sample volume (5 µl) for RNASeq. The entire 
cDNA sample was used for the Illumina Nextera XT sample preparation (Illumina, 
Cat# FC-131-1024, San Diego, CA) following the manufacturer’s instruction. 
Prior to normalization, we analyzed 5 µl from each sample using the High 
Sensitivity DNA Assay (Agilent Technologies, Santa Clara, CA) for quality control 
purposes. After sample preparation, each sample was given a unique DNA 
barcoded index during Tagmentation and library preparation, according to 
standard protocols (Illumina, Cat# FC-131-1002, San Diego, CA). Pooled 
libraries were loaded into the MiSeqTM platform (Illumina, San Diego, CA) using a 







4.2.4 Data analysis 
The filtered Fastq files generated from the MiSeq run were trimmed by the 
Purdue Genomics Core Facility to remove the index and adapter sequences. The 
Fastq files were uploaded into CLC Genomics Workbench (CLC Bio, Cambridge, 
MA) for analysis. We downloaded individual rRNA sequences from Mus 
musculus [45S rRNA (NR_046233.1); 28S rRNA 5’end (M19226.1); 28S rRNA 
3’end (K01366.1); 18S RNA (NR_003278.3); and 5.8S rRNA (J01871.1)] from 
NCBI (http://www.ncbi.nlm.nih.gov/nuccore/) (Pruitt et al., 2009) and assembled 
them into one contig that represented the entire, unprocessed 45S rRNA using 
Sequencher 5.0 (Gene Codes, Ann Arbor, MI). See figure 4.1 for an explanation 




Figure 4.1 Mammalian rRNA prcessing 
The 45S pre-rRNA is transcribed by RNA Polymerase I. It is processed into 
mature 18S, 5.8S, and 28S rRNAs by endonucleases and exonucleases, which 
cleave the external (ETS) and internal transcribed spacers (ITS). This figure is 







ITS1 ITS2 5’ETS 18S 5.8S 28S 45S rRNA 










We delineated the 5’ETS, ITS1 and ITS2 domains to the full-length, in silico-
assembled unprocessed rRNA transcript and then mapped the MiSeq reads from 
each sample to the 45S rRNA sequence under the following parameters: 
similarity fraction 0.9, length fraction 0.5, nonspecific map-ignored. The 
remaining parameters were set to default values. We used this data to generate 
the coverage table that shows the coverage at each base pair (bp). To quantitate 
the levels of 28S, 18S, 5’ETS, and ITS2 transcripts, determined the range of 28S, 
18S, 5’ETS, and ITS2 in our reference contig, and then averaged the coverage 
within the range of 28S, 18S, 5’ETS, and ITS2. For example, 5’ETS starts from 
bp 1 to bp 4008 in the 45S contig, we then averaged the coverage between bp 1 
to bp 4008 to denote the average coverage of 5’ETS. To reduce amplification 
bias, we normalized the 28S coverage to 18S, and normalized ITS2 to 5’ETS. 
Since ITS2 is cleaved when the 32S transcript is processed into the 28S rRNA, 
we are able to quantify the levels of 32S rRNA and 28S RNA by comparing the 
coverage between ITS2 and 28S sequence. We computed the ratio between 
normalized ITS2 and normalized 28S, and then compared this ration between 


















4.3.1 TRP53 Is Activated in Mutant Embryos 
Previously, our data indicates that apoptosis occurs at E4.5 in mutant embryos 
(Lossie et al., 2012). Although we failed to detect altered Trp53 expression in 
mutant embyros (Lossie et al., 2012) , we hypothesized that TRP53 is activated 
in our mutants. To test that hypothesis, we performed immunocytochemistry to 
detect expression of acetyl-K378 TRP53 (equivalent to K381 in human) in 
Nle1l11Jus1/l11Jus1 embryos at E3.5 and E4.5 (Fig. 4.2, Table 4.2). Acetylation of 
lysine 378 by p300/CBP has been shown to activate TRP53, which induces 
transcription of downstream genes, eventually leading to apoptosis (Kim et al., 
2012; Xu et al., 2011). Using single logistic multiple regression, we determined 
that acetyl-K378 TRP53 is found solely in homozygous mutants (Likelihood Ratio 
χ2 = 31.69, P<0.0001) at E3.5 (LR χ2 = 16.57, P<0.0001) and E4.5 (LR χ2 = 
15.01, P = 0.0001). We did not find any evidence for an interaction between 
genotype and stage (LR χ2 < 0.0001; p>0.9999), suggesting no difference was 
found between E3.5 and E4.5 with the same genotype. Overall, these data 
indicate that TRP53 is activated at both E3.5 and E4.5, suggesting that apoptotic 
phenotype could be mediated by acetylation of TRP53.  
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Figure 4.2 Acety-K378 TRP53 expression in Nle1 embryos 
Acety-K378 TPR53 detection in wild-type and mutant embryos at E3.5 (200X) 
and E4.5 (200X). Active TRP53 is only detected in the mutants. Red staining 
indicates the presence of acetyl TRP53 signal and green is the Hoechst staining. 















Table 4.2 Logistic multiple regression analysis of active TRP53 detection 
Stage 129/129 L1/129 L1/L1 Total 
Acetyl-K378 
TRP53 
+ – + – + – 
 E3.5 morula/ 
blastocyst 
0 7 0 9 3 0 19 
E4.5 hatched 
blastocyst 
0 9 0 3 3 0 15 
 
4.3.2 Altered Gene Expression in the Cell Cycle and Apoptosis Pathways  
Acetylation of Lysine 378 by p300/CBP activates TRP53, which activates 
transcription of downstream genes, eventually leading to apoptosis (Kim et al., 
2012; Xu et al., 2011). Previously, we showed that Cdkn1a is upregulated in the 
mutants at all stages (morula, blastocyst and hatched blastocyst), and several 
members of the Wnt pathway are down-regulated (Lossie et al., 2012). Since 
Cdkn1a is a transcriptional target of p53 that controls cell cycle regulation, we 
wanted to determine if mutant embryos display misregulation of additional p53 
target genes and/or genes involved in the cell cycle. Therefore, we analyzed 
expression of CyclinE1 (Ccne1), CyclinG1(Ccng1), Cdk9, Mad21, Plk1, Bax and 
Mdm2 between wild-type and Nle1l11Jus1/l11Jus1 mutant embryos at both the morula 
and E3.5 hatched blastocyst stages using Taqman assays. Expression of each 
gene was normalized relative to expression of Gapdh and compared to stage-
matched wild-type controls. Wild-type expression was set at a value of one. 
 
Ccne1, Ccng1 Mad2l and Plk1 are involved in cell cycle regulation (Derenzini et 
al., 2005; Mandal et al., 2010; Ren et al., 2002; van de Weerdt and Medema, 
2006; Zhao et al., 2003), while Bax is a regulator of the caspase-mediated 
apoptotic pathway (Basu and Haldar, 1998; De Angelis et al., 1998; Salakou et 
al., 2007). Mdm2 is a transcription target of p53 that functions in a feedback loop, 




2011). We used a Generalized Linear Model (GLM) to calculate DDCt and fold 
change, as well as to properly control and test for differences among the mutant 
alleles and stages of development. Our data showed that Ccne1 was expressed 
at 5.56 fold lower levels in mutant morulae compared to wild-type controls 
(P=0.021) (Fig 4.3A). However, we did not detect differences in Ccne1 
expression between control embryos and mutants at the hatched blastocyst 
stage (P=0.29). In contrast, Cdk9 expression was 3.22 fold decreased in the 
mutant hatched blastocysts (P=0.0066) (Fig 4.3A), but was not significantly 
altered at the morula stage (P=0.68). Ccng1, Mad2I and Plk1 expression did not 
differ between control and mutant embryos at either stage. Mdm2 and Bax were 
highly up-regulated in hatched blastocysts (Mdm2: P=0.047; Bax: P=0.041) (Fig 
4.3B), but were not significantly different at the morula stage.   
 
In addition, our NOTCH PCR array data revealed that several genes in the Wnt 
pathway were down-regulated in mutant embryos (Lossie et al., 2012). To 
determine if the canonical Wnt pathway is altered, we analyzed β-catenin 
expression. We confirmed that β-catenin was expressed at 2.63 fold lower levels 
in mutant hatched blastocysts (P=0.041), which suggests that the canonical Wnt 
pathway could be disrupted in our mutants. 
 
Overall, we found stage-specific downregulation of Ccne1, Cdk9, and β-catenin 
in Nle1 mutants, while Mdm2 and Bax were highly up-regulated. CCNE1 (Cyclin 
E1) is required for progression through the cell cycle at the G1/S transition 
(Mandal et al., 2010), and CDK9 is involved in the replication stress response in 
S phase (Zhang et al., 2013). Therefore, down-regulation of Ccne1 and Cdk9 
indicates that mutant embryos display a major defect at the G1/S transition, 
which is consistent with previous studies showing that the G1/S transition is 
blocked under ribosomal stress (Derenzini et al., 2005; Volarevic et al., 2000). 
Therefore, increased levels of Mdm2 and Bax are expected, as Mdm2 and Bax 




caspases-dependent apoptosis (Ard et al., 2002; Basu and Haldar, 1998; 
Salakou et al., 2007). This result supported our previous finding that showed the 









Figure 4.3 Altered gene expressions in Nle1 mutants 
Genes that were mis-regulated in the mutants were displayed in fold changes by 
comparing wilt-type (WT) and mutant expression. Fold change of the wild-type is 
set to one. (A) Down-regulated genes included Ccne1 in mutant morulae 
(P=0.021), Cdk9 in mutant hatched blastocysts (P=0.0066), and β-catenin in 
mutant hatched blastocysts (P=0.041). (B) Up-regulated genes are Mdm2 









































4.3.3 rRNA Processing Is Disrupted in the Nle1 Mutants 
Studies in yeast demonstrated that NLE1 (called Rsa4 in yeast) functions in the 
sequential processing of the 32S pre-rRNA to the mature 28S rRNA (Figure 4.1) 
(Bassler et al., 2010; de la Cruz et al., 2005). Cleavage of internal transcribed 
spacers 2 (ITS2) produces the mature 28S rRNA transcript. If NLE1 participates 
in murine rRNA processing, we expect to observe a disruption of 32S to 28S 
rRNA processing in our mutants as we predict the function of NLE1 to be 
conserved across species. To test this, we quantified all potential rRNA products 
using RNASeq. Because it is difficult to get enough amount of RNA from 
embryos to perform Northern blot for quantifying rRNA, RNAseq circumvents the 
technical limitations (i.e. obtaining nanogram quantities of starting material) 
encountered with pre-implantation embryos and allows us to directly sequence 
and quantify all of the rRNA products in individual embryos.  
 
We compared the rRNA expression in four wild-type E3.5 morulae and four 
mutant morulae. The reason for choosing morulae is that we hypothesize that 
disruption in rRNA processing is the primary cellular insult to the mutant embryos.  
Since we observed alteration in gene expression as early as the morula stage, 
we expect to see disruption in rRNA processing at or before the morula stage. If 
mutation in NLE1 leads to a reduction of 28S rRNA and an accumulation of 32S 
rRNA, we would expect to see increased levels of internal transcribed spacers 2 
(ITS2) in the mutants. Based on the rRNASeq results, we detected a 2.65 fold 
higher coverage of ITS2/28S in the mutants (P=0.022, t-test) compared to wild 
type embryos (Fig. 4.4, Table 4.3), while the 18S, 5.8S and total 28S coverage 
show no differences (p≥0.82), indicating that only the 32S/28S processing is 





Figure 4.4 RNASeq analysis of rRNA processing 
(A) Gene structure of 45S rRNA. Black boxes indicate the mature 18S, 5.8S and 
28S region, and black lines are the external or internal transcribed spacers 
(5’ETS, ITS1 and ITS2) a, b, c, and d denote the coverage regions that are 
corresponding to the formula in Table 4.3 (B) Heat map of rRNASeq coverage in 
45S rRNA. The average coverage from 4 biological replicates was used to 
generate this heat map. The overall coverage ranges from 0 to 730 counts. (C) 
Quantification on the relative amount of ITS2/28S rRNA, which is based on the 
average coverage on the ITS2 and 28S regions. Student t-test was performed to 
determine significance (P=0.022). 
  
Table 4.3 Average coverage of each rRNA subunits 
 
ITS1 ITS2 























































































mutant 7.86 259.128 3.564 197.516 156.482 2.205 1.312 1.681
mutant 1.778 97.609 1.046 80.091 68.154 1.7 1.219 1.395 1.953 2.65
mutant 12.616 721.356 4.908 730.794 540.121 2.572 0.987 2.606
mutant 3.21 71.953 2.179 104.02 34.454 1.473 0.692 2.13
WT 3.034 219.827 3.127 324.31 201.421 0.97 0.678 1.431
WT 0.501 19.741 1.019 32.006 24.211 0.492 0.617 0.798 0.737 1
WT 3.076 391.521 3.53 321.034 308.852 0.871 1.22 0.715
WT 0.002 352.162 0.263 291.704 241.369 0.007 1.207 0.006
Formula a b c d =a/c =b/d =(a/c)/(b/d)
T le 4.3 Averag  coverage at each rRNA subunits 
P value= 0.022 by Student t-test




Abnormal ribosomal biogenesis is usually coupled with disrupted nucleolar 
structure (Gallenberger et al., 2011; Zhang et al., 2008). Therefore, we examined 
nucleolar structure by detecting the expression pattern of fibrillarin, a nucleolar 
protein. In the E3.5 mutants, we observed circular stainings of fibrillarin (Fig. 4.5), 
which is similar to the structure of immature nucleolus precursor body in E2.5. In 
mice, the inactive nucleolus precursor body is gradually organized into a 
functional nucleolus during four- to eight-cell stages and is disappeared in morula 
stage. For the E3.5 wild-type embryos, fibrillarin staining shows clear punctate 





Figure 4.5 Immunofluorescent images of nucleolar structure 
(A) Embryos at indicated stages were stained for fibrillarin (red), showing in the 
middle panel. Nucleus is labeled using Hoechst fluorescent blue dye (left panel) 
(200X). Fibrillarin staining reveals the morphology of nucleolar precursor body in 
E2.5 wild-type embryo. At E3.5, the nucleoli are smaller than E2.5 stage. In the 
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E3.5 mutant blastocyst and hatched blastocyst, fibrillarin staining show a circular 
structure (yellow arrows in (B)) that resembles nucleolar precursor body in E2.5, 
while the E3.5 wild-type embryo displays normal punctate structure (blue arrows 






























The I11Jus1 and l11Jus4 alleles harbor missense mutations in the Nle1 gene 
(Lossie et al., 2012). Studies in Drosophila and Xenopus indicate that NLE1 is a 
member of the NOTCH pathway that functions as a negative regulator of Notch 
signaling (Cormier et al., 2006a; Royet et al., 1998b). However, our previous data 
refuted the possibility that NLE1 functions as a negative regulator of NOTCH 
signaling during mammalian pre-implantation development, as mutation of Nle1 
does not lead to increased expression of key Notch downstream target genes. 
On the contrary, reports in yeast and plants (which lack NOTCH signaling) 
demonstrate a role for NLE1 in ribosomal biogenesis (Chantha et al., 2007a; 
Chantha et al., 2006; Chantha and Matton, 2007; de la Cruz et al., 2005b; Strain 
et al., 2001).  
 
Here, we present evidence that support a role of NLE1 in ribosomal biogenesis in 
mammalian pre-implantation development, as l11Jus1 and l11Jus4 mutants 
show disruption in 32S/28S rRNA processing and abnormal nucleolar structures. 
Furthermore, Nle1 mutants displayed abnormal activation of TRP53 at both E3.5 
and E4.5, disruptions in the cell cycle and eventual apoptosis. The big question is 
what is the initial insult that leads to activation of TRP53, and initiation of the 
apoptotic mechanism. We provided evidence here that the causative insult is 
likely induction of ribosomal stress that occurs due to mutations in Nle1. 
Activation of TRP53 induces expression of TRP53 target genes, including 
Cdkn1a (Lossie et al., 2012), Bax and Mdm2. Activation of Cdkn1a can cause 
cell cycle arrest, which is also supported by our data, since Ccne1 (Cyclin E1) 
(which controls GS/S transition) and Cdk9 (which regulates replication) are 
down-regulated in the E3.5 mutants, implicating a disruption in G1/S transition. 
Previously, we determined that E4.5 mutants were undergoing caspase-
dependent apoptosis (Lossie et al., 2012), which can be initiated by the 




It is not surprising that mouse embryos with defects in genes that encode for 
proteins involved in ribosomal biogenesis fail during pre-implantation 
development. For example, mutations in multiple proteins involved in ribosomal 
rRNA synthesis and processing (e.g. pescadillo-1 (PES-1) (Lerch-Gaggl et al., 
2002), RNA polymerase 1 (Yamamura et al., 2008), SURF6 (Romanova et al., 
2006), RBM19 (Zhang et al., 2008), EMG1 (Ding et al., 2010), WDR36 
(Gallenberger et al., 2011), LIN28 (Vogt et al., 2012)) cause embryonic lethality 
at the morula stage. However, at a gross level, our mutant phenotype appears 
around E4.5-E5.5 as they implant but fail to outgrow. This delayed phenotype is 
probably due to compensation by other protein.  
Other WD40 proteins play important roles in rRNA biogenesis. WDR12, which 
contains an NLE1 domain and several WD40 repeats (Nal et al., 2002), shares 
34.8% identity to NLE1 on the protein level, as determined by the SIM program 
(http://web.expasy.org/sim/) (Huang and Miller, 1991) and on the cDNA level 
(Kolmogorov-Smirnov P-value=0.0467) (Pearson, 1996). The yeast WDR12 
homolog, Ytm1, and the NLE1 homolog, Rsa4, both interact with the AAA+-
ATPase Rea1 in directing rRNA processing, (Bassler et al., 2010; Bottcher et al., 
2009). Disruptions of Ytm1 and Rsa4 block processing of the 35/27S precursor 
rRNA to the mature 25S and 5.8S rRNAs (Bassler et al., 2010) (In mammals, 
these correspond to 36/32S pre-rRNA, 28S rRNA and 5.8S rRNA). Based on the 
findings described above, it is possible that the function of NLE1 and WDR12 
overlap, therefore mutation in NLE1 causes a slightly later phenotype. We can 
test this hypothesis by disrupting Wdr12 in the Nle1 mutants to see if the 
embryos arrest earlier.  
The association between ribosomal stress and TRP53 activation still needs to be 
determined in our mutants. Several studies reported that ribosomal stress 
induces the RP(Ribosomal protein)-MDM2-p53 pathway (Daftuar et al., 2013; Dai 
and Lu, 2004; Gilkes et al., 2006). That is, disruption of rRNA biogenesis 




MDM2 and inhibit p53 degradation, thereby activating p53 the apoptotic pathway. 
To test if the RP-MDM2-p53 pathway is activated in our mutants, our next step 
will be to investigate the possible interaction between ribosomal proteins and 
MDM2 in our system.  
Together, our data implicate NLE1 in ribosomal biogenesis that mediates cell 
cycle arrest and apoptosis via TRP53 signaling. Intriguingly, ribosomal 
biogenesis is critical for pre-implantation development in mice as described 
before. These pathways could provide novel targets for the design of therapeutic 














5.1 NLE1 and Its Potential Biological Function in Ribosomal Biogenesis 
Through conducting positional cloning and sequencing analysis, we determined 
that the l11Jus1 (L1) and l11Jus4 (L4) phenotypes are caused by non-
conservative missense mutations in the Nle1 gene. l11Jus1 and l11Jus4 were 
generated by N-ethyl-N-nitrosourea (ENU) mutagenesis on the C57BL/6J (B6) 
background, which also contains a non-conservative missense mutation in Nle1. 
Therefore, l11Jus1 and l11Jus4 homozygotes harbor two mutations within the 
predicted functional domain of NLE1. Although the endogenous C57BL/6J 
mutation is not lethal, it potentially interacts with the L1 and L4 mutations, as 
there is significant loss in viability of l11Jus1 and l11Jus4 on the C57BL/6J 
background (Lossie et al., personal observation).  
 
NLE1 belongs to the WD40 repeat family of proteins; it contains eight WD40 
repeat-like domains and a NLE domain at the N terminus. The L4 mutation and 
B6 mutation are located in the second WD40 domain, while L1 is in the sixth 
WD40 domain. Despite the differences in L1 and L4 alleles, the phenotype is 
indistinguishable and the gene expression data between l11Jus1 and l11Jus4 
are not significantly different (Lossie et al., 2012). Gene targeting studies also 
indicate that the mutant phenotypes of l11Jus1 and l11Jus4 phenocopy the null 
allele (Cormier et al., 2006a). These data suggest that these two single point 
mutations in the coding region are each sufficient to disrupt protein function. ENU 
mutagenesis has demonstrated that single point mutations can recapitulate the 





Pax6 mutations generated by ENU mutagenesis, out of those, seven mutations 
expressed phenotypes characteristic of null alleles (Favor et al., 2001). A mouse 
model of the Human Fragile X Syndrome that harbors a missense mutation in 
Fmr1I304N (created by targeted knock-in approach) also displayed Fmr1 null-like 
phenotypes, including increased audiogenic seizure rates, decreased acoustic 
startle responses, and greater exploratory behavior (Zang et al., 2009).  
 
The fact that L1 and L4 phenocopy the null allele suggests that the WD40 repeat 
domains are critical for the function of NLE1. The eight WD40 repeats in NLE1 
are predicted to form a ‘β-propeller’ structure serves as a role for protein-protein 
interaction. The L1 and L4 mutations may cause structural change to the β-
propeller in NLE1 that disrupts the interaction between NLE1 and its binding 
partner, leading to a malfunctioned protein complex. So far, no protein in the 
WD40 family has been found to display enzymatic activity (Xu and Min, 2011). 
WD40-repeat proteins usually comprise components within higher order 
molecular complexes that are responsible for sequential or simultaneous 
interactions. In addition to the interaction through the β-propeller motif, WD-
repeat proteins may have other functions provided by the N- or C-terminus (Nal 
et al., 2002; Steimle et al., 2001).  
 
NLE1 and WDR12 are structurally similar; they both contain an NLE domain and 
WD40 repeats. WDR12 is a critical component of the PeBoW complex in 
mammalian cell lines. The PeBoW complex contains PES1 (pescadillo), BOP1 
(block of proliferation) and WDR12. It is required for maturation of the 60S large 
ribosomal subunit and for cell proliferation in rat fibroblasts(Holzel et al., 2005; 
Rohrmoser et al., 2007). Knocking down Pes1 and Bop1 by dominant negative 
mutations or siRNA technology blocks processing of the 36/32S precursor rRNA 
into the mature 28S rRNA and 5.8S rRNA, and subsequently disrupts maturation 
of the 60S large ribosomal subunit.  Maturation of the 40S small subunit is not 




of cell cycle in G1 phase and growth arrest (Eick et al., 2006; Holzel et al., 2005; 
Pestov et al., 2001b). 
 
The PeBoW complex is conserved throughout evolution (Rohrmoser et al., 2007; 
Woolford et al., 2008). The yeast PeBoW ortholog (Nop7, Erb1 and Ytm1 are 
orthologs of Pes1, Bop1, and WDR12 respectively) is also involved in ribosome 
biogenesis and cell cycle progression (Miles et al., 2005). Similar to the 
mammalian systems, ablation of the proteins leads to disruption in large 
ribosomal subunit maturation (Miles et al., 2005; Oeffinger et al., 2002). Woolford 
et al. (2008) further identified how these three proteins interacting with each and 
what are the interacting domains in each of the three proteins. Specifically, Erb1 
and Nop7 form a heterodimer, and then Ytm1 is recruited to assemble into a 
preribosome (Miles et al., 2005). The recruitment of Ytm1 stabilizes the 
association between Erb1 and Nop7. Erb1 serves as a bridge that connects 
Ytm1 and Nop7 via its N-terminus (Pestov et al., 2001a; Woolford et al., 2008). 
Ytm1 binds to the N-terminus of Erb1 through its C-terminal WD40 domain, while 
Nop7 interacts with Erb1 via the central region (Woolford et al., 2008).  
 
Since NLE1 and WDR12 are the closest known family members, I predict that 
NLE1 interacts with analogous proteins through the WD40 repeats to form a 
protein complex that is similar to PeBow. By searching the Saccharomyces 
Genome Database (SGD) (http://www.yeastgenome.org/) (Cherry et al., 2012), I 
determined 44 proteins that interact with Rsa4. Out of them, 33 proteins are 
involved in ribosomal biogenesis and the rest are involved the other processes 
such as DNA replication and ubiquitination. Interestingly, Erb1 and Nop7 are a 
subset of these 44 proteins reported by a very recent study (Ohmayer et al., 
2013). It is likely that NLE1 forms a complex with Erb1 and Nop7 to exhibit the 





The functional relationship between NLE1 and WDR12 has been identified in 
yeast. The orthologs for WDR12 (Ytm1) and NLE1 (Rsa4) both interact with the 
ATPase, Rea1 (Bassler et al., 2010; Bottcher et al., 2009). Rea1 is a conserved 
pre-ribosomal factor found in the nucleoplasm that is a component of the pre-60S 
ribosomal subunit (Galani et al., 2004; Nissan et al., 2004). Rea1 is required for 
the formation of 60S. It is necessary for processing of ITS2 from the 32S rRNA to 
28S rRNA and is specifically involved in a late step that generates the mature 
5.8S rRNA from the 7S pre-rRNA (Fig. 1.4) (Galani et al., 2004). Electron 
microscopy demonstrated that Real1 contains two major domains: an ATPases 
Associated with cellular Activities (AAA) motor domain that binds to the pre-60S 
particles, and a long flexible tail harboring a metal ion-dependent adhesion site 
(MIDAS) (Bottcher et al., 2009). The Rea1 MIDAS domain contacts the N-
terminal NLE domain of Ytm1 and Rsa4 directly and sequentially during 60S 
subunit biogenesis. Therefore, the NLE domain can also be called the MIDAS 
interacting domain (MIDO) (Bassler et al., 2010; Bottcher et al., 2009).  
 
A conserved glutamate (E114 in Rsa4 and E80 in Ytm1) in the MIDO is essential 
for interacting with MIDAS (Bassler et al., 2010; Bottcher et al., 2009). Both Ytm1 
(WDR12) and Rsa4 (NLE1) share this conserved amino acid. This site is 
necessary for proper, sequential exportation of the 60S subunit from the 
nucleolus to the cytoplasm. Mutations in this glutamate residue in Ytm1 cause an 
early block at the transition of 60S from the nucleolus to the nucleoplasm 
(Bassler et al., 2010). The analogous glutamate mutation in Rsa4 inhibits 
exportation of the pre-60S particles from the nucleoplasm to the cytoplasm 
(Bottcher et al., 2009). Since Ytm1 is recruited first to the pre-ribosomal particle 
in the nucleolus, it is possible that Ytm1 and Rsa4 share the same binding site on 
the pre-60S subunit and the yeast PeBoW complex blocks the association of 
Rsa4 to the nucleolar pre-60S transcript until it is ready to be exported to the 
cytoplasm. How Rea1 mediates the replacement of Rsa4 from Ytm1 is still 




that in mammalian, Rea1 homolog (MDN1) drives a similar interaction between 
NLE1 and WDR12 during 60S ribosomal biogenesis. I speculate that MDN1-
mediated export of the 60S transcript from the nucleolus to the nucleoplasm, and 
from the nucleoplasm to the cytoplasm occurs through interactions with WDR12 
and NLE1, respectively (Fig. 5.1). To test that, future studies could be conducted 
to determine the interaction of WDR12 and NLE1 with MDN1 by co-
immunoprecipitation and immune-FLIM-FRET detection to identify the 
intracellular localization of these proteins and protein complexes. This could be 
conducted in embryonic stem cells from Wdr12 and Nle1 mutants. Furthermore, 
these studies could be designed to examine the distribution of pre-60S subunits 
after mutation of the MIDO domain of within NLE1 and WDR12, and 









Figure 5.1 Proposed model for the biological function of NLE1 
The ATPase MDN1 acts at distinct, successive 60S biogenesis steps. The MDN1 
MIDAS domain interacts directly with the N-terminal MIDO domain of WDR12. 
MDN1 then releases WDR12 from pre-60S particles in an ATP-dependent 
manner. The released WDR12 is replaced with NLE1 to direct the nuclear exit of 
pre-60S particles (modified from Baßler et al, 2010). 
 
 
5.2 The rRNASeq study   
To the best of my knowledge, we are the first to use RNASeq to analyze rRNA 
processing. The most common ways to study rRNA processing are by Northern 
blot and pulse-chase labeling of rRNA by 32P-orthophosphate. These methods 
require significantly more RNA than can be obtained from a single blastocyst. For 
example, northern blot require a minimum of 20 µg of total RNA or 4 µg of mRNA 
(Bergeron et al., 2001). However, a 64-cell embryo produces approximately 1 ng 
of total RNA. It is prohibitive to collect and genotype enough embryos to conduct 













question, there are significant potential biases with this technique. First, there are 
several repetitive sequences in the rDNA, which means that each set of primers 
must be thoroughly validated prior, and although polymorphisms exist in the 
repetitive sequences (James et al., 2009), this experiment requires that primers 
be designed for specific regions of the transcript, which may or may not span 
enough polymorphisms to ensure accurate amplification, which  can lead to non-
specific binding. Second, it is difficult to determine the appropriate control for 
these experiments. 18S rRNA is often used as a control because it is less variant 
in expression level under normal condition. However, in our case we are 
uncertain if 18S rRNA proceesing is also disrupted. Third, in order to quantify 
different rRNA subunits, one needs to design and validate multiple primer sets. 
To overcome these limitations and difficulties, we took an advantage of the Next 
Generation Sequencing (NGS) technology. We used the Illumina MiSeq platform 
and Nextera Sample Preparation kit to sequence total RNA in individual embryos. 
Nextera system only requires 1 nanogram of input material and uses a limited 
number of cycles of PCR amplification for library preparation. As we expect 1 
nanogram of total from one blastocyst, the Nextera system allows us to perform 
rRNASeq in single embryo. RNASeq overcomes many of the limitations of 
northern blot and reduces the amplification bias of qRT-PCR. RNASeq also 
allows us to quantify all of the rRNA products in one single experiment.   
 
We are able to assemble the raw reads from MiSeq to the 45S pre-rRNA. By 
comparing the coverage of different rRNA subunits between the mutants and the 
wildtype, we detected a 2.65 fold higher coverage of ITS2 in the mutants. This 
indicates a block of processing from the 32S rRNA to the 28S rRNA because 
ITS2 is being cleaved during this process under normal condition. This result is 





5.3 Mutations in NLE1 Affect Wnt Signaling  
NLE1 was first identified in Drosophila by a suppressor screen of the notchoid 
phenotype (Royet et al., 1998b). The same research group also determined that 
NLE1 is a regulator in the Notch pathway. Based on this evidence, we 
hypothesized initially that NLE1 is also involved in Notch signaling during mouse 
pre-implantation development. However, our Notch PCR array data refuted this 
possibility as none of the Notch receptor, ligands, or downstream targets were 
misregulated in the l11Jus1 mutants. To our surprise, several genes in the Wnt 
pathway were downregulated. Using Taqman qRT-PCR assays, we determined 
that β-catenin is expressed at lower levels in the mutants in comparison to wild-
type embryso, indicating that the canonical Wnt pathway is potentially 
downregulated, at least at the transcriptional level.  
 
The mechanisms underlying disruption of Wnt signaling in the Nle1 mutant needs 
to be elucidated. As we demonstrated that TPR53 is activated in the mutant 
embryos, it is possible that Wnt is regulated by TRP53. Since TRP53 inhibits 
self-renewal and promotes differentiation of human ES cells (Jain et al., 2012), 
the mutants could be inducing Trp53 in an attempt to differentiate cells stuck in a 
pluripotent state that was brought on by abnormal Wnt signaling. Interestingly, 
this study links upregulation of Trp53 with induction of microRNA-34 (miR-34). 
This miRNA cluster is a link between the TRP53 and Wnt pathways (Kim et al., 
2011); miR-34a, miR-34b and miR-34c are direct transcriptional targets of TRP53, 
as activation of TRP53 mediated by DNA damage or oncogenic stress induces 
miR-34 expression. Chromatin-immunoprecipitation and luciferase assays further 
showed that TRP53 binds to and activates transcription of the miR-34 genes (He 
et al., 2007). MiR-34a also regulates TRP53 through post-transcriptional binding 
to SIRT1, which inhibits translation. SIRT1 deacetylates and reduces activity of 
TRP53, thereby increasing the active form of TRP53 and inducing expression of 
TRP53 targets such as Cdkn1a and Puma (Yamakuchi et al., 2008). As a result, 





Kim and colleagues (2011) further demonstrate that TRP53 and miR-34 are 
negative regulators of canonical Wnt signaling. Loss of TRP53 function by 
conditional knock out, siRNA, or introduction of mutant p53 in human cell lines all 
lead to increased expression of b-Catenin, WNT1 and LRP6. Loss of miR-34a by 
addition of anti-miR-34a RNAs also induced Wnt activity by preventing binding of 
miR-34a to its cognant sequences on Wnt1, Wnt3, Lrp6 and β-catenin (Kim et al., 
2011). These studies uncover the interaction of TRP53 and Wnt pathways by the 
intermediate of miR-34a. 
 
Therefore, we expected miR-34a to be overexpressed in the Nle1 mutants. 
However, we did not find significant upregulation of miR-34a in mutant embryos 
from the 16-cell stage through the hatched-blastocyst. The expression levels of 
miR-34a are quite variable in this study; some cells show marked upregulation, 
while others do not. It is possible that the variable expressivity we found resulted 
from the inability to precisely stage each embryo. In addition, determining 
differential expression of microRNAs is difficult, as they often display subtle 
changes in expression (Stadler et al., 2010), which increases the difficulty of 
detecting differences in expression. Furthermore, since we showed that the 
transcript levels, but not the protein levels of β-catenin were downreguated, and 
miR-34a most often act to inhibit translation, other mechanisms could account for 
regulating the transcription of β-catenin.  
 
Another inhibitory effect of TRP53 on β-catenin is through the ubiquitin-
proteasome system, which requires an active glycogen synthase kinase 3β 
(GSK3β) (Sadot et al., 2001). GSK3β has been shown to phosphorylate β-
catenin, thus targeting it for proteosome degradation (Wu and Pan, 2010). 
Induction of wild-type TRP53 by transfection or DNA damage down-regulates β-
catenin. The reduction in β-catenin levels was accompanied by abatement in the 




proteasome degradation. Mutating the N terminus of β-catenin prevented this 
effect, where the N terminus compromises degradation of β-catenin by the 
proteasomes. Blocking GSK3β activity or overexpressing the dominant-negative 
ΔF-β-TrCP also prevents β-catenin degradation (Sadot et al., 2001).  
 
DNA damage (induced by camptothecin) activates the nuclear pool of GSK3β 
with no activation of the cytosolic pools (Bijur and Jope, 2001). This research 
group determined that TRP53 interacts with GSK3β in the nucleus following DNA 
damage. Furthermore, they found that binding of TRP53 to GSK3β increases the 
activity of GSK3β, and that activated GSK3β induces transcriptional activity of 
Trp53 (Bijur and Jope, 2001). Under normal conditions, GSK3β regulates TRP53 
levels through phosphorylation of the central domain of MDM2. For efficient 
degradation of TRP53, MDM2 required this phosphorylation within the central 
domain to maintain the low basal levels of TRP53 (Kulikov et al., 2005).   
 
As previously discussed, ribosomal stress induces the release of ribosomal 
proteins (RPs) from the nucleolus, allowing RPs bind to MDM2, thereby TRP53-
MDM2 complexes are disrupted, stabilizing TRP53 (Deisenroth and Zhang, 
2011). Under these conditions, TRP53 is increased, which allows TRP53 to bind 
to GSK3β, thereby resulting in increased levels of active GSK3β. When GSK3β 
is activated, it phosphorylates β-catenin, leading to proteasome degradation of β-
catenin. This can further mediate down-regulation of β-catenin and Wnt signaling. 
To test if this model is true in our mutants, we can determine if GSK3β is 
expressed at higher levels and bound to TRP53 in the nucleus of the mutants.  
 
5.4 Altered Nucleolar Structure and p53 Activation in the Mutant 
Using immunostaining with antibodies targeting Fibrillarin, we determined the 
Nle1 mutant blastocysts and hatched blastocysts show nucleolar structures that 
are similar to the immature nucleolar precursor bodies (NPB). The nucleolus 




established in the pronuclei after fertilization. The NPB appear as a clear sphere 
delineated from the surrounding nucleoplasm (Flechon and Kopecny, 1998). The 
sphere is composed of a dense meshwork of thin fibrils. In mice, the inactive 
nucleolus precursor body is gradually organized into a functional nucleolus 
during four- to eight-cell stages. The zygotic nucleolus is developed mainly 
limited to the surface of NPB, while the core of the original NPB remains compact 
and is still detectable up to the morula stage (Flechon and Kopecny, 1998; 
Maddox-Hyttel et al., 2007). The fact that we detected an NPB-like structure in 
mutant blastocysts indicates a potential delay in mature nucleoli formation.   
 
In our mutant blastocysts, not all of the blastomeres display NPB-like structures. 
If the L1 and L4 mutations in Nle1 can mediate abnormal nucleolar structure, and 
NLE1 is expressed throughout the embryo, we would expect all of the 
blastomeres to show altered nucleolar structure. However, only some of the cells 
in the inner cell mass show this defect, indicating that NLE1 may not be 
expressed equally in every blastomere. In addition, activated TRP53 is not 
expressed uniformly throughout the mutant embryos; it is detected mainly in the 
inner cell mass. This leads us speculate if abnormal nucleoli and active TPR53 
are co-localized in the same blastomere.       
 
Recently, several studies have reported that mouse blastocysts display a salt-
and-pepper distribution of lineage-specific transcription factors (Chazaud et al., 
2006; Kang et al., 2013; Plusa et al., 2008; Xenopoulos et al., 2012). The 
emergence of the epiblast and primitive endoderm within the inner cell mass 
(ICM) of a mouse blastocyst required initial co-expression of epiblast- and 
primitive endoderm- specific markers in all cells of the inner cell mass. This is 
followed by a mutually exclusive pattern, where cells expressing epiblast- and 
primitive endoderm- specific markers are distributed in a salt-and-pepper fashion 
independent of their location within the ICM. For example, the epiblast lineage 




markers (GATA4, GATA6, SOX7 and SOX17) are mutually exclusive; cells 
express either epiblast markers or primitive endomerm markers, not both. (Artus 
et al., 2011; Chazaud et al., 2006; Meilhac et al., 2009; Plusa et al., 2008; 
Yamanaka et al., 2010). Future studies can be aimed at determining if mutations 
in Nle1 disrupt detect expression of these markers in the Nle1 mutant to 
determine if cell lineage decision is disrupted.     
  
5.5 Model for Signaling Regulation in Nle1 Mutants 
Based on our findings and other published studies, we developed a model to 
explain how Nle1 interacts in multiple pathways that are imperative for embryonic 
development (Fig. 5.2). We demonstrated that NLE1 is involved in ribosomal 
biogenesis, as the Nle1 mutants show a defect in 32S/28S rRNA processing and 
display abnormal nucleolar structure. Disruption in ribosomal biogenesis leads to 
ribosomal stress that mediates activation of TRP53 through binding of ribosomal 
proteins to MDM2 (Daftuar et al., 2013; Dai and Lu, 2004; Deisenroth and Zhang, 
2011; Gilkes et al., 2006). We confirmed that TRP53 is activated in mutant 
embryos, as acetyl-K378 TRP53 is expressed at higher levels in the mutants. 
This acetylation can be accomplished by histone acetyltransferases, CBP and 
p300 (Feng et al., 2005; Krummel et al., 2005). Activation of TRP53 induces two 
mutually exclusive pathways–cell cycle arrest or apoptosis. First, we found 
upregulation of Cdkn1a and down-regulation of cell cycle regulators, such as 
CyclinE1 and Cdk9 at E3.5. CCNE1 (Cyclin E1) is required for the G1/S 
transition, while CDK9 regulates replication at S phase. Therefore, 
downregulation of CyclinE1 and Cdk9 suggests that mutant embryos are 
arrested at the G1/S cell cycle transition at E3.5. This finding is consistent with 
previous reports that the amount of ribosomes produced can determine G1/S 
transition (Derenzini et al., 2005; Volarevic et al., 2000). When the damage 
accumulates we predict that the embryo cannot recover from cell cycle arrest. 
Therefore, the mutants undergo caspase-dependent apoptosis at E4.5 via 




mutants. How WNT being misregulated is still unclear. As previously discussed, it 
could be regulated by activation of TRP53, which triggers GSK3β activity and 
proteasome degradation of β-catenin, leading to inhibition of the WNT signaling 
(Sadot et al., 2001).             
 
To further support our model, future studies will need to be conducted. First, we 
want to determine if ribosomal proteins bind to MDM2 to activate TRP53. Second, 
we want to investigate if GSK3β is the link between TRP53 and Wnt signaling in 
our model. Last, we want to identify the biological function of NLE1 in ribosomal 
biogenesis. We propose that NLE1 has the same function as determined in yeast 
that it is responsible for the transportation of 60S ribosomal subunit from 
nucleoplasm to cytoplasm via binding to MDN1 (Bassler et al., 2010). 
Biochemical studies such as co-immunoprecitiation and FRET can be used to 
determine this interaction.  
  





Figure 5.2 Proposed model for the regulatory network in Nle1 mutants 
I propose mutations in NLE1 lead to ribosomal stress and activation of the RPs-
MDM2-p53 pathway. Activation of p53 mediates upregulation of Cdkn1a and cell 
cycle arrest. When the mutants cannot recover from cell cycle arrest, they 
undergo caspase-dependent apoptosis. Downregulation of the Wnt signaling 
may result from activation of GSK3β via TRP53. GSK3β phosphorylates β-
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• Improved the isolation and differentiation of mouse/swine 
mesenchymal stem cells (MSCs) into neurons. Obtained 




















LEADHERSHIP EXPERIENCE  
   Student mentor, Purdue University 
• Supervise undergrads and rotating grad students to help them 
complete their works 
• Plan daily schedule for new comers in the lab and check their 
progress 
• Provide support and advices to mentees in choosing courses 
and labs 
          
   Teaching assistant: Teach labs and recitations at BIOL111   
   Fundamentals of Biology II  
• Introduced concept and requirement to students and assisted 
them in their exercise 
• Reviewed lecture materials, led group discussion and graded 
assignments  
 
   Resident assistant, National Taiwan University 
• Coordinated orientation and social activities for residences  


























• Data Collector Interns of Hunger in America Study, Food 
Finders Food Banks, Inc 
! Interact with clients at local food pantries and help clients take 
surveys 
! Information collected will help the public better understand 
food insecurity in our local area and help Food Finders 
provide better services 
• ABE 691 Life of a Faculty Entrepreneur: Discover, 
Development, Translation  
! Presented a business plan for a biotech startup company 
! Learned technology development and commercialization 
strategies  
• Associate staff at the Center for International Agricultural 
Education and Academic Exchange, National Taiwan University 
(NTU) 
! Interacted with colleges in China and in the US to establish 
exchange agreements  
! Introduced Taiwanese culture and biodiversity to 
international scholars  
• Web manager at Department of Animal Science and 
Technology, NTU  

























• Fluent in English and Mandarin writing, speaking and listening 
• Certificate in Good Clinical Practices (GCP) and Good Document  
• Molecular Techniques  
! DNA, RNA isolation from single blastocysts  
! Library preparation and data analysis for next-generation sequencing  
! Bisulfite sequencing and methylation-specific PCR  
! qRT-PCR (Taqman, SYBR green) 
• In situ hybridization, Immunocytochemstry, cloning and genotyping 
• Rodent Husbandry Techniques 
! Dissection for mouse embryo collection from E0.5 to E13.5 
! Maintaining, breeding and weaning of mutant mouse lines 
! Euthanasia by carbon dioxide inhalation and cervical dislocation  
• Data Analysis 







• Judge at Lafayette Regional Science and Engineering Fair 
• Raised fund to Purdue Badminton Club for equipment 
maintenance and traveling 
• Taught science to K6-12 students at Burnett Creek Elementary 
school, West Lafayette, IN, Sunnyside Middle School, Lafayette 
• Coordinated orientation and social activities for incoming 
Taiwanese student  
• Decreased the usage of disposable tableware and printer paper 
at National Taiwan University when joining the Roots & Shoots 







Oct 2011  
May 2010- 




• Student Scholarship to IMGC, International Mammalian Genome 
Society         
• LOUJA Graduate Travel Award. Purdue Animal Sciences   
• 1st Place of Graduate Student Poster Competition, Purdue Animal 
Sciences   
• Travel award, Purdue PULSe Graduate Office   
• Presidential Award, National Taiwan University 




• The Genetic Society of America (GSA) 
• International Mammalian Genome Society (IMGS) 
• American Society of Animal Science (ASAS) 
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